Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014973	li-borrabm	— (—)	5107	5477	100.00%	Distribution not available
3014973	li-borabmv	— (—)	34	36	100.00%	Distribution not available
3014973	li-borrabm	AU/ml (au/ml)	19	23	0.00%
3014973	li-borabmv	AU/ml (au/ml)	13	14	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other demyelinating diseases of the central nervous system

378

156

31.71

307.65

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1610

3070

3.57

307.65

1.1

3.37

26.14

au/ml

—

Viral infections of the central nervous system, including avohilmo

374

343

12.13

307.65

1.2

1.1

54.18

4.24

au/ml

—

Polyneuropathies and other disorders of the peripheral nervous system

584

801

7.67

307.65

1.1

47.45

16.78

au/ml

—

Symptoms and signs involving the nervous and musculoskeletal systems

1330

2550

5.39

307.65

1.1

44.08

24.38

au/ml

—

Other symptoms and signs involving the nervous and musculoskeletal systems

968

1841

5.45

307.65

1.1

16.91

15.59

au/ml

—

Headache

1256

2077

4.78

307.65

1.1

37.62

17.99

au/ml

—

General symptoms and signs

1511

2215

3.47

307.65

1.1

33.44

17.99

au/ml

0.42

Other and unspecified polyneuropathies, also in other diseases

495

675

7.71

307.65

1.1

54.00

9.67

au/ml

—

Neurological diseases

1360

819

8.51

307.65

1.1

1.0

22.80

2.45

au/ml

—

Other neurological diseases

1114

2527

3.48

291.04

1.1

55.00

22.91

au/ml

—

Malaise and fatigue

781

1451

4.32

275.69

1.1

42.68

17.65

au/ml

—

Symptoms and signs involving the skin and subcutaneous tissue

1121

3481

3.09

255.74

1.1

37.83

25.10

au/ml

—

Autoimmune diseases related-to ILD

1257

3703

2.88

245.32

1.1

25.33

28.93

au/ml

—

Autoimmune diseases excluding thyroid diseases

1430

2883

2.72

223.25

1.1

20.45

36.83

au/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

1397

2795

2.75

222.91

1.1

20.45

27.69

au/ml

—

Convulsions, not elsewhere classified

438

816

5.45

218.72

1.1

—

14.21

—

Fever of other and unknown origin

743

1827

3.57

209.72

1.1

54.69

16.55

au/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1159

2880

2.83

208.67

1.1

26.77

18.07

au/ml

—

Implicit Sepsis, including avohilmo

1117

2865

2.82

202.56

1.1

26.77

18.07

au/ml

—

ILD medications: immunosuppressive drugs

941

2890

3.00

201.48

1.1

21.59

24.09

au/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1202

3061

2.68

195.43

1.1

26.77

18.87

au/ml

—

ILD medications

1456

3168

2.50

193.65

1.1

20.52

24.09

au/ml

—

Meningitis

203

208

10.72

179.07

1.3

1.0

51.67

—

au/ml

—

Implicit Sepsis

974

2694

2.70

163.91

1.1

26.77

18.99

au/ml

—

Spirochaetal infections, other/unspecified, including avohilmo

549

1605

3.50

155.01

1.1

31.99

4.70

au/ml

—

Lyme disease

546

1596

3.50

154.21

1.1

31.99

4.70

au/ml

—

Lyme disease, including avohilmo

546

1596

3.50

154.21

1.1

31.99

4.70

au/ml

—

Other spirochaetal diseases

548

1613

3.48

153.09

1.1

31.99

4.70

au/ml

—

Other spirochaetal diseases, including avohilmo

551

1634

3.45

152.12

1.1

31.99

4.70

au/ml

—

Medical observation and evaluation for suspected diseases and conditions

782

1339

3.02

143.69

1.1

3.06

7.64

au/ml

—

Autoimmune diseases

1302

2894

2.30

143.06

1.1

4.17

36.83

au/ml

—

Nerve, nerve root and plexus disorders

1276

3436

2.25

139.50

1.1

42.85

18.27

au/ml

0.76

Used for control exclusion in common control thyroid runs

1216

2653

2.33

136.99

1.1

4.17

24.87

au/ml

—

Viral Sepsis

344

801

4.40

134.30

1.1

30.92

11.44

au/ml

—

Other soft tissue disorders, not elsewhere classified

1154

2853

2.32

133.53

1.1

40.17

20.88

au/ml

—

Implicit viral Sepsis, including avohilmo

449

1270

3.60

132.73

1.1

49.09

18.91

au/ml

—

Implicit viral Sepsis

341

799

4.37

132.05

1.1

30.92

11.44

au/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

1229

3097

2.23

128.14

1.1

25.67

24.09

au/ml

—

Cerebral palsy and other paralytic syndromes

248

459

5.62

127.81

1.1

—

4.24

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

782

2740

2.51

119.17

1.1

55.05

19.27

au/ml

—

Delirium, not induced by alcohol and other psychoactive substances

208

351

6.09

117.44

1.1

—

4.24

—

Dorsalgia

1129

2737

2.20

113.75

1.1

56.74

18.69

au/ml

—

Cerebral cysts

166

232

7.59

113.45

1.1

—

Benign intracranial hypertension

24.82

109.14

1.1

—

Other dorsopathies, not elsewhere classified

1135

2747

2.16

108.82

1.1

47.71

18.69

au/ml

—

Low back pain

904

2667

2.31

108.32

1.1

46.24

18.69

au/ml

—

Papilloedema, unspecified

107

13.01

106.69

1.1

—

Other antidepressants

1116

2654

2.16

106.51

1.1

45.87

17.11

au/ml

—

Pain in limb

967

2795

2.22

103.94

1.1

46.79

20.88

au/ml

—

Diseases of the eye and adnexa

927

2032

2.31

102.01

1.1

39.87

5.75

au/ml

—

Speech disturbances, not elsewhere classified

183

330

5.76

97.07

1.1

—

3.52

—

First line medication for Crohn's disease

1207

3305

1.98

92.87

1.1

21.41

23.71

au/ml

—

Oral corticosteroids

1153

3480

1.96

87.87

1.1

23.21

23.09

au/ml

—

Lower back pain or/and sciatica

1177

3822

1.93

87.17

1.1

51.25

15.04

au/ml

1.25

Use of teriflunomide

19.25

86.84

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

656

1339

2.50

86.28

1.1

27.03

7.64

au/ml

—

Second line medication for Crohn's disease

696

3113

2.26

86.12

1.1

28.92

21.29

au/ml

—

L04AX Other immunosuppressants

675

3012

2.27

84.13

1.1

28.92

21.29

au/ml

—

Inflammatory bowel disease treatment related agents

1226

3623

1.89

83.35

1.1

20.97

23.09

au/ml

—

Opioids

1054

2738

2.00

82.98

1.1

44.92

19.29

au/ml

—

Dorsopathies

1072

2765

1.98

81.10

1.1

30.87

18.69

au/ml

—

Small fibre neuropathy

106

9.79

80.02

1.1

—

Symptoms and signs involving speech and voice

418

1532

2.77

79.95

1.1

—

14.09

—

Codeine

994

2697

2.01

79.68

1.1

75.00

19.29

au/ml

—

Sequelae of cerebrovascular disease

365

1085

2.91

73.99

1.1

—

16.61

—

Pain (limb, back, neck, head abdominally)

683

1517

2.27

73.12

1.1

19.38

20.90

au/ml

—

Other intervertebral disc disorders

819

2426

2.03

69.40

1.1

87.00

19.38

au/ml

—

Tramadol

799

2406

2.01

66.42

1.1

44.10

19.86

au/ml

—

Soft tissue disorders

1037

2878

1.86

65.77

1.1

38.42

20.88

au/ml

—

Any gastric operation

804

2015

2.02

64.14

1.1

4.52

18.52

au/ml

—

GASTRO-related operations

804

2015

2.02

64.14

1.1

4.52

18.52

au/ml

—

Other anxiety disorders

585

2319

2.17

63.80

1.1

—

14.60

—

Abnormalities of breathing

930

2856

1.88

62.48

1.1

46.20

18.50

au/ml

—

Other and unspecified visual disturbances

174

434

4.12

62.43

1.1

—

4.84

—

Sciatica+with lumbago

539

2189

2.20

61.55

1.1

68.00

20.87

au/ml

—

Persons encountering health services for examination and investigation

588

1339

2.22

59.72

1.1

15.19

7.64

au/ml

—

Parasetamol

749

1908

2.00

58.59

1.1

18.02

4.18

au/ml

—

Pain in throat and chest

870

2778

1.87

58.15

1.1

31.21

18.50

au/ml

—

Persons encountering health services for specific procedures and health care

1092

3725

1.74

58.08

1.1

40.02

24.60

au/ml

—

Benzodiazepine use

1018

3929

1.76

57.84

1.1

33.72

26.05

au/ml

—

Codeine or tramadol medication

1124

3543

1.73

57.82

1.1

67.10

18.84

au/ml

—

Bacterial infection, other or unspecified

529

2125

2.12

54.49

1.1

56.92

13.33

au/ml

—

Other specific joint derangements/joint disorders

809

2736

1.86

53.81

1.1

22.68

17.30

au/ml

—

Bacterial meningitis

137

6.72

53.38

1.3

1.0

60.80

—

au/ml

—

Bacterial infection, other or unspecified, including avohilmo

574

2341

2.03

52.20

1.1

56.92

13.33

au/ml

—

Other and unspecified degenerative diseases of nervous system

9.25

51.83

1.1

1.0

—

Spondylopathies

704

2176

1.93

51.78

1.1

28.87

22.19

au/ml

0.13

Other acute disseminated demyelination

13.50

51.59

1.2

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

992

2864

1.75

51.42

1.1

18.61

18.50

au/ml

—

Malignant neoplasm of brain

136

6.49

50.10

1.1

—

Use of peginterferon beta-1a

25.11

50.04

1.1

1.2

—

COPD differential diagnosis

736

1968

1.89

48.86

1.1

4.34

20.71

au/ml

—

ILD differential diagnosis

734

1967

1.88

48.40

1.1

4.34

20.71

au/ml

—

Other lack of coordination

10.80

48.39

1.1

—

Symptoms and signs involving the digestive system and abdomen

928

2684

1.74

47.86

1.1

10.22

31.15

au/ml

—

Excluding asthma or asthma-COPD overlap

732

1972

1.87

47.52

1.1

4.34

20.71

au/ml

—

Hemiplegia

176

5.47

46.99

1.1

—

Viral hepatitis, IBD co-morbidity

11.05

46.90

1.1

1.0

—

Systemic connective tissue disorders

362

1605

2.28

46.28

1.1

28.54

3.88

au/ml

—

Neuromuscular dysfunction of bladder

136

358

3.90

45.39

1.0

1.1

—

3.92

—

Degenerative diseases of the nervous system

302

872

2.51

44.73

1.1

—

3.94

—

Other pulmonary diagnosis

721

1972

1.84

44.71

1.1

4.34

20.71

au/ml

—

Symptoms and signs involving the urinary system

709

3009

1.79

43.73

1.1

11.82

27.76

au/ml

—

Abdominal and pelvic pain

894

2684

1.68

40.76

1.1

11.49

31.15

au/ml

—

Malignant neoplasm of eye, brain and central nervous system

177

5.11

40.61

1.1

—

Non-invasive ventilation

260

907

2.50

39.78

1.1

—

11.60

—

Monoplegia

9.24

38.38

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

913

3833

1.61

37.89

1.1

29.44

26.84

au/ml

—

Other mental disorders due to brain damage and dysfunction and to physical disease

131

380

3.51

37.85

1.1

—

3.84

—

Cervicalgia

216

832

2.63

37.77

1.1

—

4.74

—

Influenza and pneumonia

1004

3941

1.58

37.48

1.1

28.63

19.54

au/ml

—

Other bacterial diseases

845

3433

1.64

37.18

1.1

32.03

20.54

au/ml

—

Radiculopathy

161

537

3.04

36.95

1.1

—

5.53

—

Nonorganic sleeping disorders, excluding more controls

232

939

2.50

36.62

1.1

—

14.46

—

Spondylosis

455

1845

1.94

36.61

1.1

48.20

22.19

au/ml

—

Diseases of the myoneural junction and muscle

150

485

3.15

36.42

1.1

—

3.05

—

Follow-up examination after treatment for conditions other than malignant neoplasms

359

1128

2.13

36.16

1.0

1.1

—

7.64

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

809

2877

1.65

35.86

1.1

28.63

18.48

au/ml

—

809

2877

1.65

35.86

1.1

28.63

18.48

au/ml

—

Other joint disorders

866

2780

1.63

35.77

1.1

17.22

17.30

au/ml

—

Factors influencing health status and contact with health services

249

485

2.60

35.59

1.1

1.0

—

Paraplegia, diplegia of upper limbs

7.42

35.09

1.1

—

Other disorders of binocular movement

6.63

34.11

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

854

4226

1.58

33.50

1.1

28.63

27.11

au/ml

—

Metabolic disorders

842

3196

1.59

32.12

1.1

53.13

18.34

au/ml

—

COPD/asthma related infections

898

2877

1.57

31.46

1.1

23.08

18.48

au/ml

—

COPD/asthma/ILD related infections

898

2877

1.57

31.46

1.1

23.08

18.48

au/ml

—

Personality disorders, excluding more controls

265

1213

2.20

31.37

1.1

—

15.02

—

Acute upper respiratory infections

925

3605

1.54

31.31

1.1

36.28

23.38

au/ml

0.29

Injuries to the head

1021

4028

1.51

31.11

1.1

49.90

23.34

au/ml

—

Other viral diseases, including avohilmo

420

2254

1.86

31.07

1.1

66.00

23.88

au/ml

—

Other diseases of urinary system

876

3159

1.56

30.90

1.1

7.97

32.44

au/ml

—

Shoulder lesions

637

2275

1.69

30.82

1.1

35.70

25.51

au/ml

—

Acute upper respiratory infections of multiple and unspecified sites

718

3262

1.61

30.43

1.1

32.33

23.38

au/ml

—

Use of glatiramer acetate

6.92

30.21

1.1

—

Other diseases of intestines

983

3630

1.51

30.06

1.1

36.18

17.23

au/ml

—

Sleep disorders (combined)

970

3345

1.52

29.81

1.1

23.13

24.81

au/ml

—

Diseases of the ear and mastoid process

1033

3459

1.50

29.73

1.1

2.57

38.70

au/ml

—

Special screening examination for infectious and parasitic diseases

250

813

2.26

29.72

1.1

—

4.42

—

Disorders of eyelid, lacrimal system and orbit

768

3591

1.57

29.42

1.1

57.20

23.68

au/ml

—

Other bacterial diseases, including avohilmo

897

3691

1.52

28.83

1.1

28.03

20.54

au/ml

—

Fasciculation

9.38

28.39

1.0

1.1

—

Other systemic involvement of connective tissue (FG)

244

1108

2.18

28.26

1.1

28.54

14.40

au/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

958

3394

1.51

28.24

1.1

26.98

27.56

au/ml

—

Pneumonia, organism unspecified

817

3651

1.54

28.19

1.1

28.63

19.54

au/ml

—

Other functional intestinal disorders

415

2095

1.81

27.91

1.1

36.08

19.64

au/ml

—

Use of anticholinesterases

248

878

2.19

27.85

1.1

—

9.03

—

N06DA Anticholinesterases

248

878

2.19

27.85

1.1

—

9.03

—

Fall on same level

1039

3775

1.47

27.55

1.1

5.31

31.59

au/ml

—

Postviral fatigue syndrome

10.26

27.48

1.1

—

Finngen Rheumatological endpoints

881

3307

1.52

27.42

1.1

3.65

25.52

au/ml

—

Diseases of oesophagus, stomach and duodenum

939

3723

1.49

27.36

1.1

24.09

28.44

au/ml

—

977

3334

1.49

27.24

1.1

39.97

22.00

au/ml

0.41

Dermatitis

560

3365

1.64

26.43

1.1

14.08

32.84

au/ml

—

Hypertensive diseases (excluding secondary)

489

1647

1.74

26.27

1.1

21.44

27.74

au/ml

—

Cystitis

721

2748

1.57

26.15

1.1

23.03

34.07

au/ml

—

Dissociative [conversion] disorders

171

4.22

26.14

1.1

1.0

—

173

720

2.44

25.95

1.1

—

6.00

—

Diseases of the respiratory system

543

1615

1.69

25.74

1.1

3.68

22.48

au/ml

—

All pneumoniae

907

4001

1.48

25.53

1.1

28.63

19.54

au/ml

—

Pneumonias (Asthma/COPD co-morbidities)

901

3993

1.48

25.47

1.1

28.63

19.54

au/ml

—

Other systemic involvement of connective tissue

251

1225

2.07

25.45

1.1

28.54

3.88

au/ml

—

Bronchitis

955

3928

1.46

25.20

1.1

24.95

28.20

au/ml

—

Sleep apnoea

808

3388

1.51

25.05

1.1

35.36

29.50

au/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

877

3974

1.47

24.55

1.1

28.63

19.54

au/ml

—

Liquid cancers

253

1186

2.04

24.38

1.1

6.67

34.00

au/ml

—

Cluster headache, strict

128

4.58

23.71

1.1

1.0

—

Meningitis, viral

25.02

23.63

1.4

1.1

—

Abnormalities of heart beat

316

1662

1.86

23.37

1.1

—

19.91

—

Benign neoplasm of meninges

112

398

2.86

23.20

1.1

—

5.75

—

Cluster headache, wide

135

4.41

23.06

1.1

1.0

—

Acute sinusitis

496

2781

1.63

22.91

1.1

53.60

23.12

au/ml

—

Irritable bowel syndrome

274

1434

1.93

22.83

1.1

—

21.99

—

Generalized anxiety disorder

192

884

2.19

22.68

1.1

—

3.91

—

Primary_lymphoid and hematopoietic malignant neoplasms

204

965

2.13

22.54

1.1

6.60

19.26

au/ml

—

Other facial nerve disorders

102

4.97

22.39

1.0

1.1

—

Other strabismus

227

1118

2.04

22.30

1.1

—

4.57

—

Intestinal infectious diseases

826

4227

1.46

22.30

1.1

39.72

25.22

au/ml

—

Voice disturbances

244

1242

1.98

22.09

1.1

—

3.95

—

Benign neoplasm: Cerebral meninges

103

361

2.90

21.92

1.1

—

5.75

—

Sleep disorders

802

3791

1.46

21.73

1.1

22.50

22.46

au/ml

—

Other and unspecified dermatitis

460

2840

1.63

21.53

1.1

14.08

26.31

au/ml

—

Disorders of optic nerve, not elsewhere classified

5.80

21.52

1.0

1.1

—

Use of hypnotics and sedatives

907

3629

1.43

21.37

1.1

34.22

26.55

au/ml

—

Spinal stenosis

349

1459

1.77

21.24

1.1

21.20

24.21

au/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

823

3859

1.45

21.14

1.1

22.50

22.46

au/ml

—

Vocal cord dysfunction

134

474

2.51

21.13

1.1

—

16.19

—

Diarrhoea and gastroenteritis of presumed infectious origin

627

3712

1.51

21.05

1.1

39.72

25.36

au/ml

—

Use of rivastigmine

111

412

2.71

20.99

1.1

—

4.32

—

Other diseases of upper respiratory tract

903

3292

1.43

20.94

1.1

8.40

30.59

au/ml

—

Autonomic disorders

5.37

20.94

1.2

1.1

—

Pain in thoracic spine

145

618

2.37

20.69

1.1

—

4.70

—

Other shoulder lesions

103

373

2.80

20.63

1.1

—

4.20

—

Hypertension, essential

662

2481

1.51

20.55

1.1

32.14

23.90

au/ml

—

Optic atrophy

5.96

20.44

1.1

—

Optic atrophy, wide definition

5.95

20.42

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

870

3926

1.43

20.40

1.1

34.10

25.96

au/ml

—

All kidney diseases

848

3985

1.43

20.38

1.1

24.96

28.47

au/ml

—

Other and unspecified paralytic syndromes

6.87

20.23

1.1

1.0

—

Undetermined asthma

118

462

2.58

20.19

1.1

—

4.80

—

Myasthenia gravis

6.22

20.16

1.2

1.1

—

Alzheimer’s disease, strict definition

165

595

2.25

20.15

1.1

—

3.94

—

Insomnia

785

3794

1.44

20.05

1.1

22.50

22.46

au/ml

—

Dermatitis and eczema

956

4055

1.40

19.95

1.1

11.44

32.84

au/ml

—

Undetermined asthma, excluding more controls

118

465

2.56

19.92

1.1

—

4.80

—

Brain glioblastoma and astrocytoma

5.52

19.87

1.2

1.1

—

Schizophrenia or delusion, excluding more controls

251

1325

1.88

19.61

1.0

1.1

—

15.26

—

Sleep apnoea, including avohilmo

830

3523

1.43

19.55

1.1

39.69

25.14

au/ml

—

Use of dimethyl fumarate

7.87

18.94

1.0

1.1

—

Internuclear ophthalmoplegia

51.81

18.87

1.0

1.4

—

Immunodeficiency with predominantly antibody defects

4.69

18.82

1.2

1.1

—

Nonorganic sleeping disorders

232

1232

1.90

18.65

1.1

—

4.29

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

6.50

18.64

1.2

1.1

—

Encephalopathy

7.68

18.02

1.2

1.0

—

Circumscribed brain atrophy

5.67

18.02

1.1

1.0

—

Hypertensive diseases

663

2552

1.47

17.96

1.1

29.46

23.90

au/ml

—

Asthma, including avohilmo

998

4031

1.37

17.88

1.1

30.21

26.98

au/ml

—

Intestinal infectious diseases, including avohilmo, including avohilmo

954

3872

1.38

17.83

1.1

34.10

25.96

au/ml

—

Hypertension

661

2550

1.47

17.70

1.1

32.14

23.90

au/ml

—

Endocrine, nutritional and metabolic diseases

692

2417

1.45

17.10

1.1

4.32

14.12

au/ml

—

Disorders of speech understanding and production

199

3.28

16.96

1.2

1.1

—

Chronic lower respiratory diseases

1020

3990

1.35

16.76

1.1

52.10

21.81

au/ml

—

Respiratory insufficiency

191

3.27

16.43

1.1

—

3.92

—

Liquid cancers, including Hilmo

280

1434

1.73

16.37

1.1

6.67

32.63

au/ml

—

Alzheimer disease

198

731

1.95

16.25

1.1

—

3.94

—

Memory loss

289

2.81

16.20

1.1

—

4.17

—

Unspecified fall

422

2684

1.55

16.17

1.1

—

19.82

—

Brain glioblastoma

5.95

16.02

1.3

1.1

—

Nystagmus and other irregular eye movements

5.71

15.87

1.1

—

Disorders of adult personality and behaviour

285

1693

1.70

15.75

1.1

—

26.52

—

Specific development disorders of speech and language

277

2.80

15.71

1.1

—

Unspecified dementia

216

2.97

15.68

1.1

—

3.74

—

Brain glioblastoma, helper endpoint

5.72

15.40

1.3

1.1

—

Disorders of muscles

397

2.47

15.30

1.1

—

4.67

—

Injuries to the knee and lower leg

985

3996

1.34

15.26

1.1

41.34

24.92

au/ml

—

Cardiac arrhythmias

510

2212

1.48

14.91

1.1

26.60

10.06

au/ml

—

Heterophoria

379

2.49

14.85

1.1

—

3.54

—

Chronic laryngitis and laryngotracheitis

126

586

2.17

14.77

1.2

1.1

—

3.70

—

Hypokalaemia

106

461

2.32

14.61

1.2

1.1

—

4.63

—

Use of donepezil

122

536

2.18

14.47

1.1

—

3.94

—

Other diseases of the respiratory system

153

772

2.00

14.40

1.1

—

4.22

—

Other respiratory disorders and diseases

153

772

2.00

14.40

1.1

—

4.22

—

Diabetes insipidus

6.53

14.39

1.1

1.0

—

Cauda equina syndrome

5.64

14.15

1.1

—

Lesion of ulnar nerve

121

565

2.16

14.06

1.1

—

5.62

—

Neoplasms

682

2572

1.40

13.87

1.1

4.50

29.37

au/ml

—

Personality disorders

265

1601

1.67

13.82

1.1

—

22.90

—

Other degenerative diseases of the basal ganglia

4.94

13.66

1.1

—

Diseases of the skin and subcutaneous tissue

804

2983

1.36

13.63

1.1

19.50

29.67

au/ml

0.25

Cluster headache, strict, including avohilmo

245

2.79

13.40

1.1

—

Persistent mood disorders

164

873

1.89

13.24

1.1

—

13.17

—

Viral infections of central nervous system, not elsewhere classified/unspecified

6.17

13.19

1.2

1.1

—

Phobic anxiety disorders

139

701

2.00

13.09

1.1

—

4.53

—

Covid-19 suspected case

205

1174

1.76

13.04

1.1

—

20.72

—

Undefined dementia

249

2.65

12.85

1.1

—

3.53

—

Retrobulbar neuritis in diseases classified elsewhere

14.30

12.61

1.0

1.2

—

Cluster headache, wide,, including avohilmo

259

2.68

12.59

1.1

—

Disorders of refraction and accommodation

250

1523

1.65

12.45

1.1

—

10.49

—

Other bacterial intestinal infections, including avohilmo

190

1080

1.77

12.42

1.1

—

12.58

—

Dental pulpitis, including avohilmo

786

3792

1.33

12.39

1.1

4.92

25.76

au/ml

—

Specific personality disorders

229

1374

1.68

12.33

1.1

—

22.90

—

Other disorders of optic disc

4.93

12.25

1.1

—

Other heart diseases, wide

778

3543

1.33

12.23

1.1

26.60

28.52

au/ml

—

Benign neoplasm of other and unspecified endocrine glands

120

591

2.05

12.21

1.1

—

4.29

—

Other bacterial intestinal infections

144

763

1.90

11.85

1.1

—

4.34

—

Algoneurodystrophy

162

3.10

11.81

1.1

—

Emotionally unstable personality disorder

137

717

1.93

11.75

1.1

—

3.44

—

Vertigo of central origin

4.89

11.75

1.1

—

Unspecified visual impairment (binocular)

5.39

11.62

1.1

—

Transport accidents

376

2124

1.48

11.47

1.1

—

34.67

—

Varicella [chickenpox]

210

2.77

11.29

1.1

—

Other and unspecified drugs and medicaments

391

2.25

11.25

1.1

—

4.24

—

Other disorders of peripheral nervous system

10.82

11.25

1.2

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

263

1656

1.58

11.12

1.1

—

17.99

—

Chronic apical periodontitis

896

3901

1.29

11.12

1.1

6.31

33.42

au/ml

—

Benign neoplasm: Brain, supratentorial

4.64

11.05

1.1

—

Intracerebral haemorrhage

375

2.26

10.99

1.0

1.1

—

2.42

—

Bacterial intestinal infections, IBD co-morbidities

141

766

1.85

10.78

1.1

—

3.31

—

Disorders of conjunctiva

685

4027

1.32

10.66

1.1

49.34

14.63

au/ml

—

Abnormal findings on examination of blood, without diagnosis

336

2055

1.49

10.65

1.1

86.43

11.84

au/ml

—

Conjunctivitis

632

3824

1.33

10.58

1.1

36.07

14.63

au/ml

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

270

2.47

10.57

1.1

—

4.32

—

Benign neoplasms

789

3301

1.30

10.54

1.1

13.74

23.60

au/ml

—

Trochanteric bursitis

108

542

2.01

10.48

1.1

—

4.72

—

Chronic diseases of tonsils and adenoids

630

2973

1.34

10.48

1.1

19.70

22.57

au/ml

—

Alcohol use disorder, Swedish definition

417

2679

1.42

10.43

1.1

—

29.61

—

Use of riluzole

13.51

10.14

1.0

1.1

—

Other and unspecified mononeuropathies, also in other diseases

3.58

10.09

1.2

1.1

—

Hypothyroidism, other/unspecified

684

3428

1.31

10.07

1.1

40.80

24.00

au/ml

—

Non-allergic asthma (mode)

130

697

1.86

10.07

1.1

—

21.51

—

Other disorders of bone

171

1007

1.71

9.99

1.1

—

13.15

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

708

3556

1.31

9.98

1.1

40.80

25.84

au/ml

—

Use of amantadine

4.26

9.98

1.0

1.1

—

Use of fingolimod

5.38

9.96

1.0

1.1

—

Injuries to the thorax

336

2308

1.46

9.95

1.1

—

13.13

—

Reactive arthropathies

366

2.21

9.95

1.1

—

18.87

—

Non-allergic asthma (mode), excluding more controls

130

700

1.85

9.94

1.1

—

21.51

—

Enterocolitis due to Clostridium difficile

400

2.14

9.84

1.1

—

3.05

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

225

1240

1.59

9.74

1.0

1.1

—

26.00

—

Problems related to lifestyle

105

537

1.97

9.72

1.1

—

22.60

—

Abnormal findings in cerebrospinal fluid

11.03

9.70

1.2

—

Urticaria

259

1701

1.53

9.65

1.1

—

24.42

—

Hereditary ataxia

4.75

9.62

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

533

3354

1.34

9.55

1.1

26.32

28.58

au/ml

—

Diseases of pulp and periapical tissues, including avohilmo

814

3290

1.28

9.55

1.1

1.44

35.10

au/ml

—

Use of levodopa decarboxylase inhibitor

466

2.03

9.49

1.1

—

4.15

—

Other symptoms and signs involving the circulatory and respiratory systems

266

2.40

9.47

1.1

—

3.05

—

Dislocation, sprain and strain of joints and ligaments at neck level

152

881

1.74

9.45

1.1

—

4.54

—

Abnormal findings on diagnostic imaging of other body structures

112

592

1.91

9.41

1.1

—

4.37

—

Hyperhidrosis

3.46

9.35

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

336

2320

1.44

9.30

1.1

—

14.45

—

Tetraplegia

10.56

9.16

1.1

—

Infections of the skin and subcutaneous tissue

472

3436

1.36

9.13

1.1

52.61

16.50

au/ml

—

Disorders of the thyroid gland

724

3657

1.29

9.12

1.1

53.60

24.00

au/ml

—

461

2949

1.36

9.11

1.1

—

26.21

—

Mental and behavioural disorders due to alcohol

389

2658

1.40

9.07

1.1

—

27.20

—

439

2868

1.37

9.01

1.1

—

26.21

—

Other enthesopathies

216

1391

1.56

8.83

1.1

53.80

11.78

au/ml

—

Panhypopituitarism

4.22

8.78

1.0

1.1

—

Neuralgic amyotrophy

15.18

8.77

1.1

—

Dementia in Alzheimer disease

346

2.06

8.74

1.1

—

4.32

—

Alcohol abuse, main dg, excluding more controls

113

615

1.85

8.70

1.1

—

16.08

—

Other peripheral vascular diseases

342

2.16

8.62

1.1

—

5.54

—

Disorders of mineral metabolism

364

2.11

8.49

1.1

—

4.59

—

Systemic lupus erythematosus, unspecified

127

2.98

8.45

1.1

—

Other and unspecified disorders of binocular movement

10.05

8.43

1.0

1.1

—

Other and unspecified nonorganic psychotic disorders

181

1133

1.61

8.42

1.0

1.1

—

14.42

—

Paracetamol or NSAID medication

117

314

1.89

8.38

1.1

—

Soft tissue disorders related to use, overuse and pressure

189

1196

1.59

8.38

1.1

—

5.96

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

770

3859

1.26

8.37

1.1

26.18

27.79

au/ml

—

Fitting and adjustment of other devices

226

1311

1.52

8.21

1.1

—

24.43

—

Inflammatory disease of uterus

128

737

1.75

8.21

1.1

—

22.46

—

Other and unspecified spinal muscular atrophies

7.15

8.20

1.2

1.0

—

Nonhereditary hypogammaglobulinemia

4.91

8.19

1.1

—

Iridocyclitis in diseases classified elsewhere

3.60

8.03

1.3

1.1

—

Postzoster neuralgia

4.52

7.94

1.2

1.1

—

Hyperosmolality and hypernatraemia

4.74

7.93

1.1

1.0

—

Fibroblastic disorders

145

873

1.67

7.89

1.1

—

9.33

—

Sequelae of external causes of morbidity and mortality

185

1183

1.57

7.88

1.1

—

14.74

—

Unspecified mental disorder

320

2283

1.41

7.85

1.1

—

19.50

—

Secondary parkinsonism+Parkinsonism in other disease

3.35

7.83

1.1

—

Vascular dementia

200

2.42

7.79

1.2

1.1

—

3.74

—

Secondary parkinsonism

3.32

7.69

1.1

—

Hypersomnia

4.08

7.68

1.1

—

Cerebral arteritis

14.93

7.60

1.8

1.0

—

Alcohol use disorder, ICD-based

304

2164

1.41

7.59

1.1

—

14.45

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.36

7.54

1.2

1.1

—

Schizophrenia, schizotypal and delusional disorders

254

1753

1.46

7.54

1.1

—

21.25

—

Other disorders of patella

141

855

1.66

7.51

1.1

—

27.81

—

Other complications of surgical and medical care, not elsewhere classified

438

1.94

7.46

1.1

—

4.85

—

Diseases of pulp and periapical tissues and dental caries

454

1748

1.34

7.29

1.1

4.38

10.37

au/ml

—

Superficial injury of abdomen, lower back and pelvis

132

794

1.67

7.27

1.1

—

4.57

—

Other/unspecified synovitis and tenosynovitis

442

1.91

7.26

1.2

1.1

—

4.67

—

Cerebral amyloid angiopathy

9.35

7.18

1.1

—

Bruxism

3.26

7.18

1.1

—

Other congenital malformations of circulatory system

101

3.03

7.12

1.0

1.1

—

Schizophrenia or delusion

251

1750

1.44

7.09

1.0

1.1

—

21.24

—

Vertical strabismus

135

2.71

7.03

1.1

—

Haemorrhage from respiratory passages

218

1307

1.48

7.01

1.1

—

15.03

—

Plantar fascial fibromatosis

371

1.98

7.00

1.1

—

4.67

—

Abnormal weight loss

385

1.97

7.00

1.1

—

2.78

—

Other symptoms and signs involving the urinary system

414

1.92

6.94

1.1

—

2.05

—

Other and unspecified mononeuropathies of upper limb

103

2.96

6.88

1.2

1.1

—

Nonpyogenic thrombosis of intracranial venous system

5.85

6.85

1.4

1.1

—

Superficial injury of hip and thigh

109

633

1.73

6.84

1.1

—

3.71

—

Other or unspecified paralytic strabismus

7.50

6.80

1.3

1.1

—

Tobacco use

265

2.14

6.57

1.2

1.1

—

Asthma and allergy

102

581

1.74

6.56

1.1

—

5.54

—

Asthma and allergy, excluding more controls

102

582

1.74

6.53

1.1

—

5.54

—

Fall on and from stairs and steps

196

1327

1.48

6.49

1.1

—

10.74

—

Mononeuritis multiplex

10.25

6.48

1.3

1.0

—

Thiamine deficiency

6.92

6.46

1.0

1.1

—

Disorders of calcium metabolism

260

2.14

6.46

1.1

—

5.37

—

Other and unspecified urticaria

160

1041

1.55

6.42

1.1

—

3.61

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

223

1555

1.44

6.35

1.1

—

14.28

—

Diseases of oral cavity, salivary glands and jaws

375

1443

1.34

6.32

1.1

4.47

11.44

au/ml

—

Weight loss

421

1.87

6.31

1.1

—

4.32

—

Polyarteritis nodosa and related conditions

3.93

6.31

1.0

1.1

—

Other and unspecified trigeminal disorders

3.74

6.24

1.1

—

Dermatophytosis

101

593

1.71

6.16

1.1

—

4.17

—

Atypical virus infections of central nervous system, including avohilmo

4.25

6.15

1.1

—

Severe visual impairment, monocular

4.23

6.14

1.3

1.1

—

Narcolepsy and cataplexy

6.96

6.12

1.1

—

Dental caries, including avohilmo

497

1986

1.28

6.11

1.1

4.38

10.37

au/ml

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.37

6.10

1.2

—

Degeneration of the brain due to alcohol

3.21

6.05

1.1

—

Amblyopia ex anopsia

158

2.44

6.05

1.1

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

294

1352

1.38

6.01

1.1

—

29.75

—

Eosinophilic disease (BM)

3.75

5.96

1.2

1.0

—

Fracture of foot, except ankle

198

1369

1.45

5.94

1.1

—

12.11

—

Other and unspecified disorders of autonomic nervous system

7.33

5.86

1.2

1.1

—

Fracture of rib(s), sternum and thoracic spine

202

1406

1.44

5.84

1.1

—

13.44

—

Otitis externa

175

1186

1.48

5.83

1.1

—

12.11

—

Agoraphobia

143

2.48

5.81

1.1

1.0

—

Polycystic ovarian syndrome, consortium definition

544

2488

1.26

5.77

1.1

11.20

26.76

au/ml

—

Disease of hard tissues of teeth, NOS

360

1421

1.33

5.76

1.1

13.75

11.44

au/ml

—

Sequelae with surgical and medical care as external cause

137

884

1.56

5.75

1.1

—

3.87

—

Other specified and unspecified strabismus

3.80

5.69

1.2

1.0

—

Other diseases of hard tissues of teeth

367

1440

1.32

5.68

1.1

4.38

11.44

au/ml

—

Degeneration of nervous system due to alcohol

3.08

5.68

1.1

—

Other cranial nerve disorders in other disorders

10.98

5.68

1.0

1.1

—

Sequelae of inflammatory diseases of the central nervous system

10.80

5.65

1.2

1.0

—

Drug-induced systemic lupus erythematosus

6.80

5.64

1.2

1.1

—

Kela-code for severe mental illness

273

2014

1.36

5.63

1.1

—

19.44

—

Raynaud syndrome

460

1.78

5.61

1.1

—

3.54

—

Other abnormal immunological findings in serum

2.98

5.61

1.0

1.1

—

Otalgia

395

1.84

5.58

1.1

—

5.50

—

Vasomotor and allergic rhinitis

290

2112

1.35

5.57

1.1

—

22.49

—

Manic episode

111

2.65

5.50

1.0

1.1

—

Dental operations

396

1567

1.30

5.49

1.1

4.38

8.62

au/ml

—

Paralytic ileus and intestinal obstruction

156

1045

1.50

5.49

1.1

—

13.44

—

Behavioural disorders, excluding more controls

3.10

5.49

1.2

1.1

—

Anankastic personality disorder

192

2.22

5.44

1.0

1.1

—

Drug-induced adrenocortical insufficiency

3.08

5.41

1.2

1.1

—

Ménière disease

357

1.86

5.37

1.1

—

5.42

—

Disorders of brain, other and unspecified

4.87

5.36

1.0

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.24

5.34

1.3

1.1

—

Causalgia

3.35

5.34

1.2

1.1

—

Vascular dementia (other)

9.37

5.33

1.1

1.0

—

Other female pelvic inflammatory diseases

116

735

1.59

5.32

1.1

—

3.87

—

Other problems related to primary support group, including family circumstances

106

639

1.63

5.31

1.1

—

5.44

—

Convergent concomitant strabismus

268

2.00

5.28

1.0

1.1

—

Neuromyelitis optica

9.08

5.19

1.0

1.3

—

Other hearing loss

159

1049

1.47

5.18

1.1

—

10.53

—

Malnutrition

3.05

5.13

1.2

1.1

—

Malignant immunoproliferative diseases

4.84

5.05

1.1

—

Unspecified urinary incontinence

336

1.86

5.04

1.1

—

5.37

—

Disorder of external ear, unspecified

141

2.37

5.02

1.1

—

Congenital malformations of the nervous system

105

2.62

5.00

1.1

1.0

—

Hernia of abdominal wall, postoperative

107

671

1.59

4.98

1.0

1.1

—

18.62

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

155

2.29

4.91

1.0

1.1

—

Glomerular diseases

120

782

1.54

4.90

1.1

—

19.43

—

Vitamin D deficiency

2.75

4.88

1.0

1.1

—

Missing teeth due to accident, extraction or parodontitis

404

2861

1.26

4.88

1.1

56.82

11.41

au/ml

—

Alzheimer’s disease (Late onset)

103

530

1.60

4.86

1.1

—

4.32

—

Monoamine oxidase A inhibitors

429

1.74

4.82

1.0

1.1

—

3.19

—

Parkinson's disease, including avohilmo

543

1.65

4.79

1.1

—

3.71

—

Other skin changes

120

789

1.53

4.71

1.1

—

2.15

—

Transient global amnesia

315

1.85

4.71

1.1

—

4.70

—

Anaemia in chronic diseases classified elsewhere

2.75

4.70

1.1

—

Caries of dentine, including avohilmo

528

2195

1.23

4.68

1.1

3.78

10.13

au/ml

—

Other noninfective gastroenteritis and colitis

173

1223

1.42

4.68

1.1

—

4.26

—

Disorders of pituitary gland, other and/or unspecified

6.37

4.66

1.0

1.1

—

Other congenital malformations of nervous system

3.59

4.66

1.1

—

Somnolence

3.56

4.64

1.2

1.1

—

Anomalies of pupillary function

2.72

4.61

1.0

1.1

—

Mild or no visual impairment, binocular

6.08

4.51

1.2

1.1

—

Amyloidosis, other/unspecified

3.20

4.51

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

456

3514

1.23

4.48

1.1

—

22.10

—

Use of galantamine

201

2.05

4.48

1.1

—

3.03

—

Arnold-Chiari syndrome

4.19

4.46

1.1

—

Malignant neoplasm of digestive organs

116

1321

0.67

4.42

1.1

—

30.04

—

Melanocytic naevi of trunk

604

1.58

4.38

1.1

—

2.79

—

Other specified/unspecified necrotizing vasculopathies

3.40

4.35

1.1

1.0

—

Atypical virus infections of central nervous system

4.08

4.35

1.1

—

Dialysis, with operation codes

544

1.61

4.30

1.1

—

2.05

—

Other diseases of arteries and capillaries

362

1.75

4.28

1.1

—

2.39

—

Disorders of synovium and tendon in diseases classified elsewhere

2.88

4.24

1.0

1.1

—

Other and unspecified epidermal thickening

102

2.49

4.24

1.1

1.0

—

Urolithiasis

198

1461

1.36

4.21

1.1

16.89

16.35

au/ml

—

Motor disorders, excluding more controls

3.51

4.20

1.1

1.2

—

Tic and related disorders

3.47

4.19

1.1

—

Other and unspecified primary disorders of muscles

4.16

1.1

—

Other superficial mycoses

2.51

4.15

1.2

1.1

—

Other diseases of stomach and duodenum

250

1.89

4.12

1.1

—

2.78

—

Hypertensive encephalopathy

8.40

4.12

1.4

1.0

—

Sudden idiopathic hearing loss

412

1.69

4.10

1.1

—

5.45

—

Nephropathy related operations

520

1.61

4.09

1.1

—

2.39

—

Parkinson's disease

520

1.60

4.08

1.1

—

3.71

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

3.40

4.07

1.1

—

Convergence insufficiency and excess

2.99

4.04

1.4

1.1

—

Chronic kidney disease

170

1185

1.38

4.04

1.1

—

26.29

—

Muscle wasting and atrophy, not elsewhere classified

6.64

4.02

1.0

1.1

—

Other abnormal products of conception

261

1314

1.31

4.02

1.1

—

22.22

—

Patent foramen ovale

2.46

4.00

1.1

—

Dermatographic urticaria

333

1.76

3.99

1.0

1.1

—

4.24

—

Eosinophilia

2.87

3.99

1.2

1.1

—

Adhesive capsulitis of shoulder

627

1.54

3.96

1.1

—

4.67

—

Parkinson's disease, strict definition

479

1.61

3.92

1.1

—

4.15

—

Family history of certain disabilities and chronic diseases leading to disablement

248

1.87

3.89

1.1

—

Spasmodic torticollis

132

2.23

3.88

1.1

—

Other specified and unspecified disorders of eye and adnexa

145

2.16

3.88

1.0

1.1

—

Marginal zone B-cell lymphoma, including Hilmo

3.02

3.87

1.2

1.1

—

Other congenital malformations of respiratory system

9.56

3.87

1.1

1.0

—

Malignant neoplasm of digestive organs, including Hilmo

138

1424

0.71

3.84

1.1

—

30.04

—

Superficial injury of wrist and hand

162

1177

1.38

3.84

1.1

—

12.68

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.13

3.84

1.1

—

Otitis externa, unspecified

593

1.54

3.82

1.1

—

3.54

—

Behçet disease

12.57

3.80

1.0

1.4

—

Diseases of middle ear and mastoid

444

2990

1.21

3.80

1.1

3.30

21.47

au/ml

—

Personal history of risk-factors, not elsewhere classified

2.96

3.76

1.1

1.0

—

Brain astrocytoma

5.25

3.75

1.1

1.2

—

Brain astrocytoma, including Hilmo

5.25

3.75

1.1

1.2

—

Hereditary motor and sensory neuropathy

4.25

3.74

1.0

1.1

—

Other pleural conditions

347

1.71

3.74

1.1

—

3.52

—

Disorders of other and unspecified cranial nerves

5.20

3.74

1.2

1.1

—

Superficial injury of thorax

103

693

1.49

3.72

1.0

1.1

—

4.59

—

Intentional self-harm by unspecified means

3.06

3.71

1.2

1.1

—

Caries of enamel

720

4055

1.16

3.65

1.1

30.35

26.19

au/ml

—

Other viral hepatitis, including avohilmo

351

1.69

3.62

1.1

—

Toxoplasmosis, including avohilmo

4.94

3.60

1.0

1.1

—

Hyperkalaemia

191

1.95

3.58

1.1

—

4.22

—

Other and unspecified myoneural disorders

5.57

3.57

1.1

—

Moderate visual impairment, monocular

5.51

3.56

1.3

1.1

—

Diseases of peritoneum

406

1.64

3.56

1.1

—

4.85

—

Horner syndrome

2.87

3.56

1.1

—

Other disorders of binocular vision

3.10

3.55

1.1

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

6.43

3.55

1.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

489

3739

1.19

3.54

1.1

—

22.10

—

Use of interferon beta-1a

112

2.27

3.51

1.0

1.1

—

Mental and behavioural disorders due to opioids

193

1.94

3.50

1.1

1.0

—

Brain astrocytoma, helper endpoint

4.77

3.49

1.1

1.2

—

Faecal incontinence

303

1.73

3.44

1.0

1.1

—

5.20

—

Corticotropin deficiency

3.85

3.42

1.1

1.0

—

Diseases of spleen

2.70

3.41

1.0

1.1

—

107

2.27

3.40

1.1

—

Epileptic seizures related to drugs

6.05

3.40

1.1

—

Other and unspecified neuropathies

7.26

3.40

1.0

1.1

—

Melanocytic naevi

220

1707

1.29

3.38

1.1

—

18.63

—

Beningn neoplasm: Meninges, unspecified

2.88

3.38

1.1

—

Bitten or struck by other mammals

627

1.49

3.38

1.1

—

5.04

—

Alcohol withdrawal state with delirium

268

1.77

3.36

1.1

—

Conduct disorder

2.35

3.35

1.2

1.1

—

Chondropathies

111

776

1.44

3.34

1.1

—

14.29

—

Viral and other specified intestinal infections, including avohilmo

219

1636

1.29

3.34

1.1

—

20.20

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

421

1.60

3.34

1.1

—

3.65

—

Symptoms and signs involving emotional state

108

2.24

3.33

1.0

1.1

—

Car occupant injured in other and unspecified transport accidents

140

1020

1.38

3.33

1.1

—

4.77

—

Cerebral oedema

9.15

3.32

1.2

1.0

—

Acute and transient psychotic disorders

597

1.50

3.32

1.1

—

4.75

—

Complications following infusion, transfusion and therapeutic injection

2.96

3.32

1.0

1.1

—

Other dialysis

128

2.14

3.31

1.1

—

GI-bleeding

176

1328

1.33

3.31

1.1

—

15.86

—

Cerebral atherosclerosis

3.68

3.30

1.2

1.1

—

Abnormal reflex

4.91

3.28

1.1

1.2

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.83

3.28

1.1

—

Heart failure and coronary heart disease

134

1286

0.73

3.28

1.1

—

26.18

—

Epidural haemorrhage

8.68

3.27

1.2

1.0

—

Other factor of the environment

3.08

3.27

1.0

1.1

—

Chronic inflammatory disorders of orbit

6.73

3.24

1.0

—

Injury of blood vessels at lower leg level

5.53

3.23

1.0

1.1

—

Disorders of phosphorus metabolism and phosphatases

5.52

3.22

1.0

—

Behavioural disorders

2.30

3.21

1.2

1.1

—

Lesion of radial nerve

137

2.06

3.17

1.2

1.1

—

Disorders in reading

2.45

3.16

1.0

1.1

—

Helminthiases, including avohilmo

186

1.90

3.16

1.0

1.1

—

Sequelae of injuries of neck and trunk

124

2.12

3.15

1.0

1.1

—

Ganglion

135

988

1.37

3.14

1.1

—

14.00

—

Marginal zone B-cell lymphoma

3.51

3.13

1.2

1.1

—

Hypogonadotropic hypogonadism

145

2.02

3.12

1.1

—

Intestinal stricture

175

1333

1.32

3.12

1.1

—

14.09

—

Any event in cancer register

661

3343

1.16

3.11

1.1

23.55

31.50

au/ml

—

Acute disseminated encephalitis/encephalomyelitis

6.38

3.11

1.1

1.0

—

Other diseases of the digestive system

175

1337

1.31

3.05

1.1

—

15.86

—

Other inflammation of eyelid

641

1.46

3.05

1.1

—

2.42

—

Hypersplenism

6.04

3.05

1.0

1.1

—

Vascular dementia (multiple infarctions)

5.04

3.05

1.4

1.0

—

Colour vision deficiencies

6.02

3.05

1.0

—

Chronic myeloproliferative disease

2.94

3.04

1.1

—

Frontotemporal dementia, wide, incl. Pick's disease

4.41

3.02

1.0

1.1

—

Familial hypercholesterolemia

506

1.51

2.97

1.2

1.1

—

4.26

—

Malignant melanoma of skin, including Hilmo

563

1.48

2.97

1.1

—

0.28

—

Glomerular disorders in diseases classified elsewhere

483

1.52

2.95

1.1

—

2.39

—

Other and unspecified vaccines and biological substances

3.55

2.94

1.1

—

Burns and corrosions

100

705

1.42

2.93

1.1

—

16.70

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.19

2.90

1.1

—

Alcohol induced polyneuropathy

3.77

2.90

1.2

1.0

—

Severe visual impairment, binocular

5.53

2.89

1.0

1.2

—

Crohn disease

691

1.42

2.88

1.1

—

5.04

—

Allergic rhinitis

235

1856

1.25

2.87

1.1

—

26.76

—

Injury of nerves at lower leg level

3.22

2.87

1.0

1.1

—

Other metabolic disorders

633

1.44

2.87

1.1

—

5.03

—

Infective dermatitis

470

1.52

2.87

1.1

—

3.76

—

Generalized epilepsy

186

1.84

2.84

1.0

1.1

—

Late syphilis

2.81

2.83

1.2

1.0

—

Viral conjunctivitis

103

2.16

2.82

1.0

1.1

—

Implicit parasitic Sepsis, including avohilmo

4.56

2.82

1.0

1.2

—

Ehlers-Danlos syndrome, including avohilmo

2.59

2.81

1.1

—

Alcohol abuse, main dg

113

821

1.38

2.80

1.1

—

14.49

—

Sequelae of injuries of head

246

1.72

2.80

1.0

1.1

—

Sleep disorders, other/unspecified

166

1.88

2.77

1.1

—

Gastroduodenal ulcer

132

981

1.34

2.77

1.1

—

17.39

—

Injury of nerves at hip and thigh level

5.19

2.76

1.0

1.3

—

Superficial injury of ankle and foot

100

714

1.41

2.75

1.1

—

5.03

—

Syndrome of inappropriate secretion of antidiuretic hormone

5.13

2.75

1.3

1.0

—

Benign neoplasm: Rectum

100

714

1.41

2.75

1.1

—

4.14

—

Familial benign pemphigus (Hailey-Hailey disease)

6.36

2.74

1.0

1.2

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

603

1.44

2.73

1.1

—

5.44

—

Malignant neoplasm, wide definition

612

3103

1.15

2.72

1.1

26.17

34.73

au/ml

—

Frontotemporal dementia

4.33

2.70

1.0

1.1

—

Endometriosis ASRM stages 1,2

128

957

1.34

2.66

1.1

—

26.36

—

Unspecified event, undetermined intent

2.14

2.66

1.0

1.1

—

Nummular dermatitis

343

1.58

2.65

1.0

1.1

—

2.39

—

Previous suicide attempt

2.60

2.64

1.1

—

Lagophthalmos

2.98

2.63

1.3

1.1

—

Other or unspecified common variable immunodeficiency

4.88

2.63

1.0

1.1

—

Dermatitis due to substances taken internally

228

1.72

2.63

1.1

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.41

2.63

1.3

1.0

—

Other maltreatment syndromes

155

1.89

2.62

1.1

—

Foreign body in alimentary tract

236

1.71

2.62

1.2

1.1

—

Intercostal neuropathy

4.75

2.61

1.1

—

Other disorders of the musculoskeletal system and connective tissue

646

1.41

2.61

1.1

—

4.59

—

Polyarteritis nodosa

4.09

2.59

1.0

1.2

—

Congenital malformations of the circulatory system

103

726

1.38

2.59

1.0

1.1

—

4.32

—

Kidney transplant status

260

1.67

2.58

1.0

1.1

—

Synovial hypertrophy, not elsewhere classified

4.06

2.58

1.0

1.2

—

Acute generalized exanthematous pustulosis

185

1.80

2.57

1.1

—

Hereditary hypogammaglobulinemia

5.65

2.57

1.0

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

5.63

2.57

1.0

1.2

—

Senile degeneration of the brain, not elsewhere classified

7.32

2.56

1.0

1.1

—

Erythema intertrigo

2.15

2.56

1.1

—

Senility

5.49

2.54

1.0

—

Malignant neoplasm, including Hilmo

608

3100

1.14

2.54

1.1

26.17

34.73

au/ml

—

Collagenous colitis

419

1.51

2.53

1.1

—

5.54

—

Pruritus

517

1.46

2.53

1.1

—

5.04

—

Benign neoplasm: Rectum, anus and anal canal

110

811

1.36

2.52

1.1

—

9.67

—

Gastric ulcer

659

1.40

2.51

1.1

—

10.15

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

380

1.54

2.51

1.1

—

Other specified/unspecified hearing loss

340

1.57

2.51

1.1

—

5.45

—

Drug-induced tremor

3.55

2.50

1.0

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

317

1.59

2.49

1.1

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

4.48

2.49

1.0

—

Biological medication for rheuma

134

1020

1.32

2.49

1.1

—

16.03

—

Toxoplasmosis

3.92

2.49

1.0

1.1

—

Drug-induced headache, not elsewhere classified

3.91

2.49

1.3

1.1

—

Disorders of male genital organs in diseases classified elsewhere

3.90

2.48

1.4

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

383

2958

1.18

2.48

1.1

27.61

24.00

au/ml

—

Other disorders of male genital organs

151

1.87

2.47

1.1

—

Tic disorders

2.59

2.46

1.2

1.1

—

Protein-energy malnutrition of moderate and mild degree

3.18

2.45

1.3

1.0

—

Myopia

722

1.38

2.45

1.0

1.1

—

3.64

—

Viral conjunctivitis, including avohilmo

181

1.78

2.44

1.1

1.0

—

Polyarthrosis

106

702

1.36

2.44

1.1

—

4.64

—

Labyrinthitis

5.18

2.43

1.5

1.1

—

Noninfectious colitis NAS

664

1.39

2.42

1.1

—

4.55

—

Other disorders of the genitourinary system

489

1.46

2.42

1.1

—

5.75

—

Crohn disease (strict definition, require KELA)

320

1.57

2.41

1.1

—

Other viral hepatitis

328

1.57

2.41

1.1

—

Event of undetermined intent

328

1.56

2.41

1.0

1.1

—

Acrodermatitis continua

6.59

2.41

1.0

1.3

—

Specific developmental disorder of motor function

2.46

2.40

1.1

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

6.52

2.40

1.0

1.3

—

Nonsuppurative otitis media, including avohilmo

240

1699

1.22

2.40

1.1

—

21.64

—

Crushed, pushed or stepped on by crowd or human stampede

409

1.50

2.39

1.1

—

Atrial septal defect

174

1.79

2.38

1.0

1.1

—

Early lumbar disc prolapse operation

633

1.40

2.38

1.0

1.1

—

20.96

—

Melanocytic naevi of upper limb, including shoulder

104

2.04

2.37

1.0

1.1

—

Acne, including avohilmo

190

1228

1.26

2.37

1.1

—

22.29

—

Gonarthrosis [arthrosis of knee](FG)

455

2258

1.16

2.37

1.1

12.80

22.26

au/ml

—

Disorder of thyroid, unspecified

2.86

2.35

1.1

—

Acute alcohol intoxication, ICD10

139

1073

1.30

2.35

1.0

1.1

—

16.72

—

Communicating hydrocephalus

2.28

2.35

1.2

1.0

—

Hernia

630

3701

1.13

2.34

1.1

36.90

20.88

au/ml

—

Other diseases of pancreas

355

1.53

2.32

1.1

—

5.12

—

Impotence

199

1.72

2.32

1.0

1.1

—

Tic and related disorders

2.41

2.31

1.1

—

Other bacterial agents as the cause of diseases classified to other chapters

2.99

2.29

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments of thorax

148

1.84

2.29

1.1

—

Unspecified threat to breathing

2.80

2.29

1.0

1.1

—

severe traumatic brain injury, does not include concussion

118

894

1.32

2.29

1.1

—

16.53

—

Sleepwalking [somnambulism]

4.06

2.29

1.3

1.1

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

2.78

2.28

1.0

1.1

—

Radial styloid tenosynovitis [de Quervain]

223

1.67

2.28

1.1

—

4.20

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

4.00

2.27

1.1

—

Superficial injuries involving multiple body regions

106

2.00

2.26

1.2

1.1

—

Common variable immunodeficiency

3.19

2.25

1.2

1.1

—

Malignant neoplasm

583

3010

1.14

2.25

1.1

26.17

34.73

au/ml

—

Disorders of magnesium metabolism

3.17

2.24

1.1

—

Metabolic disorder, other/unspecified

5.75

2.23

1.0

—

Late syphilis, including avohilmo

2.36

2.23

1.2

1.1

—

Other abortion

2.74

2.22

1.0

1.1

—

Tracheo-bronchomalasia

5.67

2.22

1.2

—

Burns classified according to extent of body surface involved

2.91

2.22

1.1

—

Lifestyle-related condition

2.72

2.22

1.0

1.1

—

Benign neoplasm: Brain, unspecified

3.42

2.20

1.1

1.2

—

Infection of intervertebral disc (pyogenic)

2.53

2.20

1.2

1.1

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.53

2.19

1.2

1.1

—

Increased muscle tone

3.40

2.19

1.1

—

Torticollis

2.27

2.19

1.2

1.1

—

Malignant neoplasm of pancreas, including Hilmo

296

0.47

2.18

1.0

1.1

—

0.28

—

Other disorders involving the immune mechanism, not elsewhere classified

129

1.88

2.17

1.3

1.1

—

Malignant neoplasm

582

3012

1.13

2.17

1.1

26.17

34.73

au/ml

—

Ulcerative ileocolitis

196

0.41

2.17

1.1

—

Other and unspecified syphilis, including avohilmo

4.42

2.17

1.0

1.1

—

Enteritis due to Yersinia enterocolitica

4.38

2.16

1.2

1.1

—

3.74

2.16

1.3

1.0

—

Muscular dystrophy

2.84

2.16

1.0

—

Spinal osteochondrosis

2.82

2.15

1.0

1.2

—

Scleritis

2.40

2.13

1.0

1.1

—

Deficiency of other B group vitamins

2.12

2.13

1.1

—

Nonsuppurative otitis media

173

1204

1.25

2.13

1.0

1.1

—

4.99

—

Burns and corrosions confined to eye and internal organs

123

1.89

2.12

1.0

1.1

—

Congenital malformations of spine and bony thorax

3.28

2.11

1.3

1.1

—

Malignant neoplasm of rectum, including Hilmo

460

0.58

2.10

1.1

—

0.28

—

Malignant neoplasm of meninges, including Hilmo

5.14

2.09

1.2

1.0

—

Toxic effect of organic solvents

5.13

2.08

1.0

1.2

—

Allergic urticaria

389

1.47

2.08

1.1

—

4.24

—

Other and unspecified injuries of ankle and foot

206

1.66

2.08

1.1

—

Malignant melanoma, including Hilmo

692

1.35

2.08

1.1

—

1.06

—

Salpingitis and oophoritis

105

796

1.32

2.07

1.1

—

3.87

—

Burn and corrosion of wrist and hand

176

1.72

2.06

1.0

1.1

—

Superficial injury of shoulder and upper arm

565

1.39

2.06

1.1

—

4.84

—

Other acute viral hepatitis

2.36

2.06

1.0

1.1

—

Other and unspecified disorders of psychological development

2.46

2.06

1.0

1.1

—

Other specified and unspecified disorders of choroid

4.12

2.06

1.0

—

Exposure to other and unspecified animate mechanical forces

154

1.77

2.05

1.0

1.1

—

Nail dystrophy

3.15

2.03

1.0

1.1

—

Ehlers-Danlos syndrome

2.54

2.03

1.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

118

1.88

2.02

1.2

1.1

—

Disorders of tooth development and eruption

111

690

1.31

2.02

1.1

—

2.30

—

Injury of nerves and spinal cord at neck level

2.07

2.02

1.1

—

Hidradenitis suppurativa

185

1.69

2.01

1.2

1.1

—

Allergic contact dermatitis

653

1.35

2.01

1.1

—

5.04

—

Malignant neoplasm of pancreas

232

0.43

2.01

1.0

1.1

—

0.28

—

Other and unspecified disorders of white blood cells

155

1.75

2.01

1.2

1.1

—

Oral lichen planus, including avohilmo , including avohilmo

311

1.52

2.00

1.0

1.1

—

6.04

—

Retinal detachment with retinal break

509

1.40

2.00

1.1

—

5.12

—

Deep endometriosis

459

1.42

2.00

1.1

—

4.70

—

Mitochondrial myopathy

3.44

1.99

1.0

1.1

—

Hydrocephalus in other diseases

3.41

1.98

1.0

—

Insulin medication

383

2760

1.15

1.98

1.1

27.61

23.25

au/ml

—

Psoas tendinitis

3.41

1.98

1.0

1.1

—

Papulosquamous disorders

244

2050

1.19

1.97

1.1

—

12.97

—

Drug-induced hypoglycaemia without coma

2.38

1.96

1.1

—

Idiopathic peripheral autonomic neuropathy

4.67

1.96

1.2

1.1

—

Palmar fascial fibromatosis [Dupuytren]

495

1.40

1.95

1.1

—

5.60

—

Symptoms and signs involving appearance and behaviour

2.77

1.94

1.0

1.1

—

Sexual dysfunction

2.02

1.91

1.0

1.1

—

Peritonsillar abscess

141

1125

1.26

1.90

1.1

—

31.58

—

Flat foot [pes planus] (acquired)

389

1.45

1.90

1.1

—

3.87

—

Retinal vascular occlusion

414

1.43

1.89

1.1

—

4.22

—

Follow-up care involving plastic surgery

143

1.76

1.89

1.3

1.1

—

Benign neoplasm: Tonsil

0.00

1.89

0.0

1.1

—

Habit and impulse disorders

2.18

1.89

1.1

—

Effects of heat and light

3.23

1.89

1.0

1.1

—

Generalized skin eruption due to drugs and medicaments

166

1.70

1.88

1.1

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

2.91

1.87

1.1

—

Nasal polyp

106

818

1.30

1.87

1.1

—

19.65

—

Blindness, monocular

2.90

1.87

1.1

—

Injuries to the hip and thigh

284

2175

1.17

1.87

1.1

—

12.76

—

Occlusion and stenosis of arteries, not leading to stroke

2.88

1.87

1.3

1.1

—

Cardiac murmurs and other cardiac sounds

419

1.42

1.86

1.1

—

4.49

—

Phlebitis and thrombophlebitis (not including DVT)

130

1031

1.26

1.85

1.1

—

12.86

—

Arteriovenous malformation of peripheral vessels

3.60

1.85

1.0

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

342

1.47

1.85

1.1

—

Later onset COPD

757

0.73

1.84

1.1

—

23.87

—

Other and unspecified syphilis

4.30

1.84

1.0

—

Postmenopausal osteoporosis with pathological fracture

190

1.64

1.84

1.2

1.1

—

5.37

—

Hyperkinetic disorders (excl. ADHD)

1.99

1.84

1.1

1.0

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

4.29

1.84

1.4

1.1

—

Dialysis

175

1.67

1.83

1.1

—

Shock, not elsewhere classified

4.21

1.83

1.4

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

587

1.35

1.82

1.1

—

5.03

—

Injury of muscle and tendon at wrist and hand level

656

1.33

1.82

1.1

—

14.66

—

Impetigo

230

1.58

1.82

1.1

—

Other disorders of thyroid

2.29

1.82

1.1

—

Specific development disorders of scholastic skills

233

1.57

1.82

1.0

1.1

—

Pyoderma

2.08

1.81

1.1

—

Asymptomatic human immunodeficiency virus [HIV] infection status

3.11

1.81

1.0

1.1

—

Other specified/unspecified disorders of bone/cartilage

123

1.80

1.81

1.0

1.1

—

Aspergillosis

3.09

1.81

1.0

—

Hypertrophy of (infrapatellar) fat pad

2.79

1.80

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

632

1.33

1.79

1.1

—

3.84

—

Retinal vascular disorders

419

1.41

1.79

1.1

—

4.22

—

Other abnormal auditory perceptions

2.37

1.79

1.0

1.1

—

Injury of nerves at forearm level

2.37

1.78

1.1

—

Other or unspecified ileus, impaction or obstruction

719

1.31

1.78

1.0

1.1

—

15.11

—

Hepatic failure, not elsewhere classified

146

1.72

1.78

1.3

1.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

375

0.58

1.77

1.1

—

0.28

—

Implicit parasitic Sepsis

3.41

1.76

1.0

1.2

—

Rosacea

643

1.33

1.76

1.1

—

4.75

—

Benign neoplasm: Prostate

3.39

1.75

1.2

1.1

—

Acute alcohol intoxication

155

1264

1.23

1.75

1.1

—

14.43

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

746

0.71

1.74

1.1

—

14.48

—

Motor disorders

2.10

1.74

1.1

—

Contusion of other and unspecified parts of foot

265

1.52

1.74

1.2

1.0

—

Syphilis

110

1.83

1.73

1.3

1.1

—

Syphilis, including avohilmo

110

1.83

1.73

1.3

1.1

—

Erosion of teeth , including avohilmo

192

1601

1.20

1.73

1.1

—

21.81

—

Preparatory care for dialysis

178

1.64

1.73

1.1

—

Blindness or visual impairment, binocular

3.92

1.72

1.0

—

Acute otitis externa, noninfective

2.15

1.72

1.0

1.1

—

Other and unspecified rosacea

423

1.40

1.71

1.1

—

5.54

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

384

0.60

1.71

1.1

—

0.28

—

Other misadventures during surgical and medical care

1.89

1.71

1.1

—

Other diseases of oesophagus

356

1.44

1.71

1.1

—

3.52

—

Other bullous disorders

1.89

1.71

1.1

—

Crohn disease (strict definition, all UC cases excluded)

258

1.52

1.71

1.1

—

Extracorporeal dialysis

250

1.53

1.71

1.1

—

Muscle strain

118

1.79

1.70

1.1

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.97

1.70

1.1

—

Malignant melanoma

612

1.33

1.69

1.1

—

1.06

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

126

1.76

1.68

1.0

1.1

—

2.53

1.67

1.3

1.1

—

Congenital malformations of spine and bony thorax, including avohilmo

2.63

1.67

1.3

1.1

—

Benign neoplasm: Spinal meninges

2.61

1.66

1.6

1.0

—

Thyrotoxicosis, other and/or unspecified

124

993

1.25

1.66

1.1

—

3.99

—

Superficial frostbite

2.85

1.66

1.0

1.2

—

Other forms of systemic lupus erythematosus

2.48

1.66

1.3

1.0

—

Aspergillosis, including avohilmo

2.84

1.66

1.0

1.1

—

Endometriosis diagnosis and infertility diagnosis occurring together

615

1.32

1.65

1.1

—

30.44

—

Other papulosquamous disorders

2.47

1.65

1.2

1.1

—

Use of antiglaucoma preparations and miotics

236

1.53

1.65

1.1

—

4.14

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

173

1.63

1.64

1.1

—

Hereditary spherocytosis

3.69

1.63

1.2

1.1

—

Syndactyly, including avohilmo

3.67

1.63

1.0

1.2

—

Viral and other specified intestinal infections

149

1191

1.22

1.63

1.1

—

3.80

—

Injury of eye and orbit

748

1.29

1.62

1.0

1.1

—

2.94

—

Atherosclerosis, excluding cerebral and coronary sclerosis

130

1260

0.81

1.62

1.0

1.1

—

27.06

—

Wegener granulomatosis

2.17

1.62

1.0

1.1

—

Flatulence and related conditions

2.53

1.60

1.0

1.1

—

Urethritis and urethral syndrome

1.92

1.60

1.2

1.1

—

Other and unspecified injuries of shoulder and upper arm

136

1.70

1.59

1.0

1.1

—

Malignant neoplasm of rectum

375

0.61

1.58

1.1

—

0.28

—

Glomerulonephritis

430

1.38

1.58

1.1

—

2.78

—

Haemolytic anaemias

137

1.69

1.55

1.1

—

Other and unspecified local infections of skin and subcutaneous tissue

440

1.37

1.55

1.1

—

4.38

—

Alcohol dependence

155

1283

1.21

1.55

1.1

—

14.43

—

Adalimumab

535

1.33

1.55

1.1

—

3.64

—

Other drug-induced secondary parkinsonism

2.46

1.54

1.0

1.1

—

Carrier of infectious disease

100

1.81

1.53

1.2

1.1

—

Complications of anaesthesia during labour and delivery

3.41

1.53

1.0

1.1

—

Chondromalacia

115

1.75

1.53

1.2

1.1

—

Other local infections of skin and subcutaneous tissue

467

1.35

1.53

1.1

—

3.72

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

386

1.39

1.52

1.1

—

0.28

—

Neuroendocrine tumor and carcinoma of lung

2.63

1.52

1.0

1.1

—

Psoriasis

173

1450

1.20

1.52

1.0

1.1

—

14.50

—

Heart failure, strict

232

1876

0.86

1.52

1.1

—

23.60

—

Benign neoplasm: Brain, infratentorial

2.91

1.51

1.3

1.1

—

Multifocal fibrosclerosis

2.91

1.51

1.0

1.1

—

Injuries involving multiple body regions

162

1.61

1.50

1.2

1.1

—

Dermatophytosis, including avohilmo

435

3819

1.12

1.49

1.1

—

24.19

—

Injury of nerves at wrist and hand level

178

1.58

1.49

1.0

1.1

—

Acute mastoiditis

2.47

1.49

1.0

1.1

—

Personal history of medical treatment

2.46

1.48

1.0

—

Hypertensive Heart Disease

108

653

1.26

1.48

1.1

—

5.76

—

Other and unspecified diseases of blood and blood-forming organs

1.82

1.48

1.0

1.1

—

Dermatopolymyositis (FG)

2.25

1.47

1.2

1.0

—

Hypertrophic cardiomyopathy

169

0.47

1.46

1.0

1.1

—

Tarsal tunnel syndrome

2.40

1.46

1.1

—

Myocardial infarction, unclassifiable

634

0.73

1.46

1.2

1.1

—

4.24

—

Other other unspecified disorders of the circulatory system

140

1.65

1.45

1.1

—

Other hypertrichosis

3.21

1.45

1.2

1.1

—

Complications of anaesthesia during the puerperium

3.20

1.45

1.0

1.2

—

Colorectal adenocarcinoma

744

0.74

1.45

1.1

—

27.05

—

Chronic viral hepatitis

277

1.45

1.1

—

Selective deficiency of immunoglobulin A [IgA]y

3.19

1.45

1.6

1.3

—

Listeriosis

3.18

1.44

1.2

1.1

—

Listeriosis, including avohilmo

3.18

1.44

1.2

1.1

—

Other and unspecified disorders of orbit

3.18

1.44

1.0

1.1

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

3.17

1.44

1.0

—

Marfan's syndrome

2.78

1.44

1.0

1.2

—

Other infections specific to the perinatal period

3.17

1.44

1.0

—

Benign neoplasm: Spinal cord

2.06

1.44

1.3

1.1

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

1.99

1.44

1.2

1.0

—

Xerosis cutis

2.05

1.44

1.1

—

Patellar tendinitis

1.99

1.44

1.0

1.1

—

Diabetes mellitus

717

3799

1.09

1.44

1.1

32.81

26.50

au/ml

—

Scabies

221

1.50

1.41

1.2

1.1

—

Diabetes, varying definitions

714

3802

1.09

1.41

1.1

27.61

27.46

au/ml

—

Injury of nerves at ankle and foot level

2.45

1.40

1.1

1.2

—

Polymyositis

2.45

1.40

1.1

1.0

—

Thyrotoxicosis

150

1253

1.20

1.39

1.1

—

4.63

—

Malignant melanoma of skin

475

1.33

1.39

1.1

—

0.28

—

All-cause Heart Failure

229

1840

0.86

1.39

1.1

—

24.77

—

Helminthiases

1.96

1.39

1.1

—

Effects of other external causes

142

1.63

1.39

1.0

1.1

—

Peroneal tendinitis

1.96

1.39

1.0

1.1

—

Psoriatic arthropathies

424

1.35

1.38

1.0

1.1

—

18.87

—

Heart failure and antihypertensive medication

123

652

1.23

1.36

1.1

—

5.98

—

Hypertrichosis

112

1.71

1.36

1.1

—

Biological medicines for asthma

1.77

1.35

1.1

—

Other disorders of Eustachian tube

120

1.68

1.34

1.1

—

Other embolism and thrombosis

513

1.31

1.34

1.0

1.1

—

4.09

—

Endometriosis of intestine

1.80

1.34

1.0

1.1

—

Certolizumab pegol

1.79

1.34

1.1

—

Solid cancers, including Hilmo

569

3024

1.10

1.33

1.1

28.56

34.73

au/ml

—

Dislocation, sprain and strain of joints and ligaments of head

192

1.52

1.32

1.0

—

Ulcerative colitis (strict) with PSC

0.00

1.32

0.0

1.1

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.75

1.31

1.1

—

Hypertensive heart and/or renal disease

118

705

1.22

1.31

1.1

—

5.76

—

Congenital hypothyroidism without goiter

2.55

1.31

1.0

1.1

—

Intentional self-harm by hanging, strangulation and suffocation

2.53

1.31

1.2

1.1

—

Exposure to uncontrolled fire in building or structure

2.53

1.31

1.2

1.1

—

Social disorders starting during childhood or adolecense, excluding more controls

2.53

1.31

1.0

1.1

—

Exposure to excessive heat of man-made origin

2.53

1.31

1.0

1.1

—

Contracture of joint

2.11

1.31

1.3

1.0

—

Inflammatory disorders of male genital organs, not elsewhere classified

2.11

1.31

1.1

—

HSIL lesion of the vulva

1.86

1.30

1.0

1.1

—

Complications predominantly related to the puerperium

175

1493

1.17

1.30

1.0

1.1

—

21.75

—

Acute gastritis

292

1.41

1.30

1.0

1.1

—

2.78

—

2.39

1.30

1.0

—

Enterobiasis, including avohilmo

106

1.71

1.30

1.0

1.1

—

Hypoplasia of dental enamel , including avohilmo

193

1.50

1.30

1.0

1.1

—

Other and unspecified nail disorders

1.77

1.29

1.2

1.1

—

Type 2 diabetes

672

3580

1.09

1.29

1.1

32.81

27.17

au/ml

—

Tumor necrosis factor alpha inhibitors

113

927

1.22

1.29

1.1

—

16.03

—

Other and specified injuries of hip and thigh

1.90

1.29

1.1

—

Endovascular or surgical operations to intracerebral aneurysms

226

1.47

1.29

1.2

1.1

—

5.04

—

Other specified/unspecified deforming dorsopathies

1.95

1.28

1.2

1.1

—

Medicines for HER+ breast cancer

142

1571

0.84

1.28

1.1

—

7.11

—

Hirsutism in women

1.73

1.28

1.1

—

Personal history of certain other diseases

1.73

1.28

1.2

1.1

—

Benign neoplasm: Pharynx, unspecified

2.32

1.28

1.3

1.1

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.31

1.27

1.3

1.1

—

Molar incisor enamel hypoplasia, with caries

2.30

1.27

1.0

1.1

—

Burn and corrosion confined to eye and adnexa

107

1.70

1.26

1.1

—

Other bursopathies

475

1.31

1.25

1.0

1.1

—

4.67

—

Benign neoplasm: Skin of lower limb, including hip

115

1.66

1.25

1.0

1.1

—

Other and unspecified disorders of adult personality and behaviour

2.44

1.25

1.0

1.1

—

Benign neoplasm: Orbit, unspecified

2.44

1.25

1.0

1.2

—

Diabetes medication

717

3871

1.08

1.25

1.1

27.61

27.46

au/ml

—

Open wound of neck

2.43

1.25

1.0

1.2

—

Benign neoplasm: Bones of skull and face

2.25

1.25

1.0

1.1

—

Folate deficiency anaemia

2.25

1.25

1.1

—

Background retinopathy and retinal vascular changes

1.87

1.24

1.2

1.1

—

Motorcycle rider injured in noncollision transport accidents

131

1.61

1.24

1.0

1.1

—

Other disorders of choroid

2.02

1.23

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

1.78

1.23

1.1

—

Peripheral arterial reconstruction

550

0.73

1.23

1.0

1.1

—

10.91

—

Von Willebrand disease

1.99

1.23

1.4

1.1

—

Unspecified transport accident

2.67

1.22

1.0

1.2

—

Congenital malformations of posterior segment of eye

2.67

1.22

1.0

1.2

—

Other congenital malformations of brain

2.67

1.22

1.0

1.1

—

Deformity of finger(s)

2.67

1.22

1.2

1.1

—

Infections specific to the perinatal period

2.18

1.22

1.1

1.0

—

Other and unspecified vascular occlusions

313

1.38

1.22

1.1

—

3.00

—

Congenital malformations of aortic and mitral valves

201

0.54

1.21

1.2

1.1

—

Cardiomyopathy (excluding other)

513

0.72

1.20

1.0

1.1

—

19.04

—

Injury of cranial nerves

2.34

1.19

1.0

1.1

—

Congenital vesicoureteral reflux

2.34

1.19

1.0

1.2

—

Acute inflammation of orbit

2.34

1.19

1.2

1.1

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.34

1.19

1.2

1.1

—

Cutis laxa senilis

2.34

1.19

1.2

—

Lesion of femoral nerve

2.33

1.19

1.0

1.2

—

Diabetic maculopathy, excluding more controls

488

1.29

1.19

1.1

—

3.05

—

Frostbite

2.13

1.19

1.0

1.1

—

Left ventricular outflow tract obstruction, narrow definition

237

0.59

1.18

1.1

—

Intentional self-harm by sharp object

125

1.61

1.18

1.1

—

Overexertion and strenuous or repetitive movements

489

1.29

1.18

1.0

1.1

—

3.54

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

165

1.52

1.18

1.2

1.1

—

Assault by blunt object

1.95

1.17

1.1

—

Other abnormalities of plasma proteins

1.95

1.17

1.1

—

Cellulitis of external ear

2.02

1.17

1.1

—

Accessory breast

0.00

1.17

0.0

1.1

—

Cystic disease of liver

0.00

1.17

0.0

1.1

—

Sequelae of other and unspecified effects of external causes

2.53

1.15

1.0

1.2

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

2.53

1.15

1.0

—

Other specified transport accidents

2.53

1.15

1.0

1.1

—

Other and unspecified intracranial injuries

110

1.65

1.15

1.1

—

Charcot foot

1.82

1.15

1.2

1.1

—

Testicular hypofunction

166

1.51

1.15

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

103

823

1.22

1.15

1.1

—

13.79

—

Injury of muscle and tendon at hip and thigh level

491

1.29

1.15

1.1

—

4.38

—

Chronic nephritic syndrome

150

1.54

1.14

1.0

1.1

—

Disorder of lipoprotein metabolism, unspecified

465

1.29

1.14

1.1

—

4.26

—

Exposure to other and unspecified forces of nature

2.37

1.13

1.0

1.2

—

Sequelae of intentional self-harm, assault and events of undetermined intent

2.37

1.13

1.3

1.1

—

Prepatellar bursitis

159

1.52

1.12

1.1

—

Presbycusis

357

1.33

1.11

1.1

—

4.75

—

Migraine, unspecified, drug-induced

2.29

1.11

1.0

1.1

—

Congenital deformities of hip, including avohilmo

1.71

1.11

1.1

—

Benign neoplasm: Adrenal gland

328

1.35

1.10

1.1

—

5.04

—

Familial hypercholesterolemia, with ischemic heart disease

311

1.35

1.10

1.2

1.1

—

3.52

—

Cholinergic urticaria

2.42

1.09

1.0

1.1

—

Other and unspecified papulosquamous disorders

2.41

1.09

1.4

1.0

—

L02BA Anti-estrogens

707

0.78

1.09

1.2

1.1

—

5.02

—

Acidosis

1.74

1.09

1.0

1.1

—

Unspecified nephritic syndrome

1.74

1.09

1.1

—

Sulfonylureas

103

984

0.83

1.09

1.1

—

25.39

—

Use of rotigotine

1.97

1.09

1.1

—

Acquired haemolytic anaemia

1.74

1.09

1.1

—

Nonalcoholic fatty liver disease

495

1.28

1.09

1.1

—

6.04

—

Vasculitis limited to skin, not elsewhere classified

1.74

1.09

1.1

—

Tularaemia

1.97

1.09

1.3

1.1

—

Dissection of cerebral arteries, nonruptured

2.22

1.09

1.1

1.2

—

Pollen allergy

138

1160

1.18

1.08

1.1

—

18.47

—

Abnormal findings in nipple discharge synovial fluid wound secretions

1.88

1.08

1.1

—

Disorder of the sleep-wake schedule

1.77

1.07

1.0

1.1

—

Other hereditary haemolytic anaemias

2.15

1.06

1.1

—

Conduction disorders

155

1068

1.16

1.06

1.1

—

30.38

—

Dyshidrosis [pompholyx]

1.81

1.05

1.1

—

Toxic effect of carbon monoxide

1.80

1.05

1.1

—

Foreign body entering into or through eye or natural orifice

401

1.30

1.05

1.0

1.1

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

1.68

1.04

1.1

—

Maxillary prognathism

2.30

1.04

1.0

1.1

—

Melanocytic naevi of ear and external auricular canal

2.30

1.04

1.2

1.0

—

Suggestive for eosinophilic asthma

393

1.30

1.03

1.0

1.1

—

5.15

—

Hereditary retinal dystrophy

1.85

1.03

1.2

1.1

—

Other and unspecified injuries of neck

2.08

1.03

1.1

—

Congenital malformations of the respiratory system

1.75

1.03

1.1

—

Colorectal cancer

895

0.81

1.03

1.1

—

35.55

—

Cushing syndrome

1.91

1.02

1.3

1.1

—

Solid cancers

542

2936

1.08

1.02

1.1

32.64

34.73

au/ml

—

Liveborn infants according to place of birth

2.05

1.01

1.1

1.0

—

Heart failure,strict

219

1723

0.89

1.01

1.1

—

24.03

—

Thyrotoxicosis with diffuse goitre

681

1.22

1.00

1.1

—

4.20

—

Carcinoma in situ of vulva

2.02

1.00

1.0

1.1

—

Other and unspecified vasculitis limited to skin

1.72

0.99

1.1

—

Localized adiposity

2.20

0.98

1.2

1.1

—

Haemorrhagic and haematological disorders of fetus and newborn

1.68

0.98

1.1

1.0

—

Perineal laceration during delivery

926

0.84

0.98

1.1

—

12.46

—

Squamous cell neoplasms and carcinoma of cervix

0.00

0.98

0.0

1.2

—

Hypocalcemia

1.68

0.98

1.1

—

Blepharospasm

1.96

0.97

1.0

1.1

—

Other specified and unspecified disorders of conjunctiva

1.96

0.97

1.1

—

Lumbosacral root disorders, not elsewhere classified

1.96

0.97

1.0

—

Alcoholic gastritis

1.87

0.97

1.2

1.0

—

Mature T/NK-cell lymphomas, hilmo

1.81

0.97

1.0

1.1

—

Perioral dermatitis

108

1.58

0.97

1.0

1.1

—

Unequal limb length (acquired)

0.00

0.97

0.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

122

1043

1.17

0.96

1.1

—

4.21

—

Complex cardiac defects

0.00

0.96

0.0

1.1

—

Contusion of ankle

199

1.41

0.95

1.1

1.0

—

Chronic hepatitis NAS

1.78

0.95

1.2

1.1

—

Cardiomyopathies, Primary/intrinsic

490

0.75

0.95

1.0

1.1

—

19.04

—

Dermatitis herpetiformis

1.79

0.94

1.1

—

Other and unspecified injuries of thorax

1.79

0.94

1.2

1.1

—

Melanocytic naevi of eyelid, including canthus

1.91

0.94

1.1

—

Nonalcoholic steatohepatitis

1.91

0.94

1.0

1.1

—

1.91

0.94

1.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

2.25

0.94

1.2

1.0

—

Sequelae of poliomyelitis, including avohilmo

2.24

0.94

1.5

1.1

—

Molar incisor enamel hypoplasia

207

1.39

0.93

1.0

1.1

—

Intestinal adhesions without obstruction

338

1.31

0.93

1.0

1.1

—

3.49

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

391

1.28

0.93

1.0

1.1

—

3.64

—

Pediculosis, acariasis and other infestations

286

1.33

0.93

1.1

—

Shoulder region

1.74

0.92

1.0

1.1

—

Contact with sharp glass

192

1.41

0.92

1.0

1.1

—

Atlantoaxial subluxation

2.17

0.92

1.0

—

Bus occupant injured in other and unspecified transport accidents

2.17

0.92

1.0

1.1

—

Seminoma of testis

2.16

0.92

1.0

1.1

—

Speech therapy

136

1178

1.16

0.91

1.1

—

8.57

—

Idiopathic thrombocytopenic purpura

118

1.53

0.91

1.0

1.1

—

Hypertrophy of tongue papillae

1.76

0.90

1.0

1.1

—

Hepatomegaly and splenomegaly, not elsewhere classified

2.09

0.89

1.2

1.0

—

Testicular dysfunction

185

1.41

0.89

1.0

—

Endocrine disorders, other/unspecified

1.70

0.89

1.2

1.1

—

Other and unspecified bullous disorders

1.92

0.89

1.0

1.1

—

Primary adrenocortical insufficiency

1.92

0.89

1.0

1.1

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

1.92

0.89

1.0

1.1

—

Alcohol-induced chronic pancreatitis

271

1.33

0.89

1.1

—

Cholecystitis

538

1.23

0.88

1.1

—

5.80

—

Caught, crushed, jammed or pinched in or between objects

263

1.34

0.88

1.0

1.1

—

Congenital deformities of hip

1.65

0.88

1.1

—

Exposure to smoke, fire and flames

1.59

0.87

1.1

—

Malignant neoplasm of heart, mediastinum and pleura

1.87

0.87

1.0

1.1

—

Drug-induced polyneuropathy

2.02

0.87

1.0

—

Other congenital malformations, not elsewhere classified

2.02

0.87

1.0

1.1

—

Other salmonella infections, including avohilmo

186

1.40

0.87

1.0

1.1

—

Other benign neoplasms of connective and other soft tissue

422

1.26

0.87

1.1

—

4.24

—

Bicuspidal aortic valve syndrome

168

0.59

0.87

1.2

1.1

—

Heart failure and bmi 25plus

126

970

0.86

1.1

—

16.71

—

Phakomatoses, not elsewhere classified

1.83

0.86

1.0

1.1

—

Colon adenocarcinoma, helper endpoint

448

0.76

0.86

1.1

—

2.67

—

Other specified and unspecified disorders of eyelid

1.83

0.86

1.3

1.1

—

Primary hyperparathyroidism

432

1.25

0.86

1.1

—

5.75

—

Dementia due to Parkinson's disease

1.67

0.85

1.1

—

Other and unspecified glaucoma

221

1.36

0.85

1.1

—

4.14

—

Autoimmune hepatitis

1.95

0.84

1.2

—

Secondary polycythaemia

1.60

0.84

1.0

1.1

—

Other salmonella infections

137

1.47

0.84

1.1

—

Adjustment and management of implanted device

614

1.21

0.84

1.0

1.1

—

3.38

—

Dermatopolymyositis

1.77

0.84

1.2

1.1

—

Benign neoplasm: Sigmoid colon

770

1.18

0.84

1.1

—

9.67

—

Infection due to other mycobacteria, including avohilmo

1.77

0.84

1.2

1.0

—

Arthropathic psoriasis

534

1.22

0.82

1.0

1.1

—

5.54

—

Osteomalacia

1.89

0.82

1.5

1.1

—

Infliximab

105

1.53

0.82

1.0

1.1

—

Chronic Coagulation defects

105

1.53

0.82

1.3

1.1

—

Anxious personality disorder

1.58

0.81

1.0

1.1

—

Motorcycle rider injured in other and unspecified transport accidents

302

1.30

0.81

1.0

1.1

—

Injury of nerves at shoulder and upper arm level

1.72

0.81

1.0

1.1

—

Crohn's disease of large intestine

250

1.32

0.80

1.1

—

Failure and rejection of transplanted organs and tissues

1.74

0.80

1.0

1.1

—

Benign neoplasm: Other/unspecified site

1.74

0.80

1.0

1.1

—

Congenital malformations of cardiac chambers and connections

0.00

0.79

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

264

1.31

0.79

1.0

1.1

—

3.27

—

Fibrosarcoma

0.00

0.79

0.0

1.2

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.79

0.0

1.1

—

Contact with venomous snakes and lizards

1.68

0.79

1.4

1.1

—

Unattended death

0.00

0.78

0.0

1.1

—

ILD medications: pirfenidone

0.00

0.78

0.0

1.1

—

Human immunodeficiency virus [HIV] disease, including avohilmo

1.57

0.78

1.1

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

1.63

0.78

1.1

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.59

0.78

1.1

1.0

—

Prurigo nodularis

1.59

0.78

1.2

1.1

—

Discontinuity and dislocation of ear ossicles

0.00

0.78

0.0

1.1

—

Iron deficiency

165

1.40

0.78

1.2

1.1

—

Alopecia areata

123

1.47

0.78

1.2

1.1

—

Colon adenocarcinoma

440

0.77

1.1

—

1.06

—

Other (not insulin) diabetes medications

636

3513

1.06

0.77

1.1

32.81

29.37

au/ml

—

Seminoma of testis, including Hilmo

1.78

0.76

1.0

1.1

—

Exophthalmic conditions

1.78

0.76

1.0

1.1

—

Fibrosarcoma, including Hilmo

0.00

0.76

0.0

1.2

—

Persons with potential health hazards related to communicable diseases

263

2381

1.10

0.76

1.1

—

18.81

—

Recurrent dislocation and subluxation of joint

332

1.27

0.76

1.0

1.1

—

3.64

—

Infection due to other mycobacteria

1.71

0.75

1.2

1.0

—

Foreign body in ear

1.61

0.75

1.1

—

Delayed puberty

2.10

0.75

1.4

1.1

—

Calcific tendinitis

2.10

0.75

1.2

1.0

—

Acquired absence of limb

2.10

0.75

1.0

—

Other surgical follow-up care

141

1.42

0.74

1.0

1.1

—

Habitual aborter

116

1.47

0.74

1.1

—

Galactorrhea

1.65

0.74

1.0

1.1

—

Assault by other specified means

1.86

0.74

1.1

—

Congenital malformations of uterus and cervix

108

1.49

0.74

1.1

—

Malignant neoplasm of testis

1.65

0.73

1.1

—

Normotensive glaucoma

298

1.28

0.73

1.2

1.1

—

5.45

—

Carcinoma in situ of skin

289

0.73

1.1

—

3.52

—

Foreign body or object entering through skin

316

1.27

0.73

1.1

—

Reiter disease

2.02

0.73

1.0

1.1

—

Toxic effect of other gases, fumes and vapours

2.02

0.73

1.0

1.1

—

Other Crohn's disease

352

1.25

0.73

1.0

1.1

—

Other bursitis of elbow

2.01

0.73

1.0

—

Benign neoplasm: Vagina

1.62

0.72

1.1

—

Contact with other hot metals

1.68

0.72

1.1

—

Adhesive middle ear disease

1.68

0.72

1.0

1.1

—

6-mercaptopurine

159

1.39

0.72

1.0

1.1

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.68

0.72

1.0

1.1

—

Other articular cartilage disorders

1.56

0.72

1.1

—

Other and unspecified acne

1.63

0.72

1.3

1.1

—

Lactose intolerance, other/unspecified

117

1.46

0.72

1.0

1.1

—

Open wound of shoulder and upper arm

1.59

0.72

1.1

—

COPD-related respiratory insufficiency

389

1.24

0.71

1.2

1.1

—

2.36

—

Other bursitis of knee

1.76

0.71

1.3

1.1

—

Achalasia of cardia

1.59

0.71

1.0

1.1

—

Ulcer of lower limb, not elsewhere classified

553

1.20

0.71

1.1

—

4.66

—

Juvenile Open Angle Glaucoma

1.94

0.71

1.2

—

Congenital dislocation of hip, unilateral

1.94

0.71

1.0

1.1

—

Disorders of plasma-protein metabolism, not elsewhere classified

1.94

0.71

1.2

1.1

—

Sequelae of poliomyelitis

1.94

0.71

1.6

1.0

—

Meningococcal infection

1.94

0.71

1.0

1.1

—

Meningococcal infection, including avohilmo

1.94

0.71

1.0

1.1

—

Other injuries of lower limb, level unspecified

1.72

0.70

1.0

1.1

—

Localized skin eruption due to drugs and medicaments

1.72

0.70

1.0

1.1

—

Fracture of forearm

336

2798

1.08

0.70

1.1

—

24.41

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.56

0.70

1.0

1.1

—

Scoliosis

355

1.24

0.69

1.0

1.1

—

6.20

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.65

0.69

1.1

—

Drug-induced obesity

1.68

0.69

1.0

1.1

—

LSIL lesion of the vagina

1.61

0.68

1.0

1.1

—

Other chondrocalcinosis

1.68

0.68

1.0

1.1

—

Acute myeloid leukaemia, helper endpoint

1.68

0.68

1.0

1.1

—

Acute myeloid leukaemia, including Hilmo

1.68

0.68

1.0

1.1

—

Acute myeloid leukaemia

1.68

0.68

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

104

883

1.15

0.67

1.1

—

13.79

—

Other congenital malformations of intestine

1.64

0.67

1.0

1.1

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

1.64

0.67

1.0

1.1

—

Adult respiratory distress syndrome

1.64

0.67

1.1

—

Biguanides

610

3483

1.06

0.67

1.1

32.81

28.26

au/ml

—

Other renal tubulo-interstitial diseases

1.50

0.67

1.1

—

Pulmonary oedema

1.63

0.67

1.3

1.1

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.80

0.66

1.0

1.1

—

Mental retardation, excluding more controls

123

1.42

0.66

1.1

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.80

0.66

1.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

1.55

0.66

1.1

—

L02BG Aromatase inhibitors

115

1284

0.88

0.66

1.1

—

7.11

—

Other congenital malformations of peripheral vascular system

1.62

0.65

1.0

1.1

—

Acute nephritic syndrome

1.58

0.65

1.1

—

Mixed conductive and sensorineural hearing loss

476

1.20

0.65

1.1

—

5.45

—

Neonatal jaundice from other and unspecified causes

1.62

0.65

1.1

—

Other hammer toe(s) (acquired)

575

1.17

0.65

1.1

—

4.64

—

Other, unspecified and serous retinal detachments

120

1.42

0.64

1.1

—

Systemic sclerosis

1.48

0.64

1.1

—

Ovarian dysfunction, other/unspecified

1.74

0.64

1.0

1.1

—

Carcinoma in situ of skin of other and unspecified parts of face

251

1.28

0.64

1.1

—

3.52

—

Vitamin B12 deficiency anaemia

368

1.22

0.63

1.1

—

3.05

—

Human immunodeficiency virus [HIV] disease

1.50

0.63

1.1

—

Thiazolidinediones

423

1.21

0.63

1.1

—

10.79

—

Schizophrenia

838

0.86

0.63

1.1

—

14.42

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

1.53

0.63

1.1

—

Occupational exposure to risk-factors

138

1.38

0.62

1.2

1.1

—

Malignant neoplasm of skin, including Hilmo

277

1715

1.08

0.62

1.1

—

30.04

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

1.65

0.62

1.0

1.1

—

Other abnormal findings in urine

1.64

0.62

1.0

1.1

—

Other chromosome abnormalities, not elsewhere classified

1.69

0.62

1.0

1.1

—

Oral leukoplakia, including avohilmo

105

0.57

0.62

1.2

1.1

—

Superficial injury of neck

1.47

0.61

1.2

1.1

—

Traumatic ischaemia of muscle

1.61

0.61

1.4

1.1

—

Respiratory tuberculosis, confirmed

1.61

0.61

1.0

1.1

—

Personal history of malignant neoplasm

352

1.22

0.61

1.1

—

5.54

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.61

0.0

1.1

—

Contusion of toe(s) with damage to nail

1.58

0.60

1.0

1.1

—

Other disorders of iris and ciliary body

1.48

0.60

1.2

1.1

—

Glaucoma, exfoliation

312

0.77

0.60

1.1

—

4.68

—

Psoriasis vulgaris

102

900

1.13

0.60

1.1

—

12.93

—

Burn and corrosion, body region unspecified

0.00

0.60

0.0

1.1

—

Contact with blunt object, undetermined intent

0.00

0.60

0.0

1.1

—

Granulosa cell carcinoma of ovary

0.00

0.60

0.0

1.1

—

Disorders resulting from impaired renal tubular function

148

1.36

0.60

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

620

3406

1.05

0.59

1.1

25.86

30.58

au/ml

—

Mastocytosis

0.00

0.59

0.0

1.1

—

Respiratory tuberculosis, confirmed, including avohilmo

1.54

0.59

1.0

1.1

—

Benign neoplasm of other and unspecified sites

131

1.38

0.59

1.0

1.1

—

Other dermatomyositis

0.00

0.58

0.0

1.0

—

Venous complications and haemorrhoids in the puerperium

1.52

0.58

1.1

—

Malignant neoplasm of palate, including Hilmo

0.00

0.58

0.0

1.1

—

Family history of malignant neoplasm

575

1.17

0.58

1.0

1.1

—

4.75

—

Pleural effusion

538

1.17

0.58

1.1

—

3.71

—

Allergic contact dermatitis due to drugs in contact with skin

1.47

0.58

1.2

1.1

—

Loose body in joint

1.47

0.58

1.0

1.1

—

Postdysenteric arthropathy

1.73

0.58

1.0

1.1

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.49

0.57

1.0

1.1

—

Burns and corrosions of multiple and unspecified body regions

1.49

0.57

1.1

—

Colorectal cancer, including Hilmo

991

0.88

0.57

1.1

—

33.71

—

Benign neoplasm of male genital organs

1.51

0.56

1.1

—

Amputation of ankle bones

1.51

0.56

1.1

—

Amputation of thigh

1.51

0.56

1.0

1.1

—

Social disorders starting during childhood or adolescence

1.63

0.56

1.0

1.1

—

Delayed milestone in childhood

1.48

0.55

1.0

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

107

1.41

0.55

1.0

1.1

—

Glaucoma secondary to eye inflammation

1.59

0.54

1.0

1.1

—

Gender identity disorders

1.51

0.54

1.0

1.1

—

Anomalies of dental arch relationship, including avohilmo

131

1069

1.11

0.54

1.1

—

5.60

—

Benign neoplasm: Long bones of lower limb

151

1.33

0.54

1.1

—

Failed attempted abortion

1.48

0.54

1.1

—

Peripheral retinal degeneration

125

1.36

0.53

1.0

—

Alcohol abuse counselling and surveillance

1.46

0.53

1.0

1.1

—

Hyphaema and other vascular disorders of iris and ciliary body

1.46

0.53

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

291

1593

1.07

0.53

1.1

—

20.66

—

Disorders of iron metabolism

1.52

0.52

1.1

—

Cerebral palsy

1.43

0.52

1.2

1.1

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

152

1.32

0.52

1.2

1.1

—

Hereditary deficiency of other clotting factors

1.51

0.52

1.3

1.1

—

Benign neoplasm: Parathyroid gland

1.51

0.52

1.0

1.1

—

Amiodarone users

348

0.80

0.51

1.0

1.1

—

2.82

—

Pneumoconiosis due to asbestos and other mineral fibres

1.50

0.51

1.0

1.1

—

Other protozoal intestinal diseases

1.41

0.51

1.0

1.1

—

Certain zoonotic bacterial diseases

1.41

0.51

1.2

1.1

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.41

0.51

1.2

1.1

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.48

0.51

1.1

—

Atrial septal defect, secundum type

126

1.35

0.51

1.1

—

1.42

0.50

1.1

1.0

—

Open wound of hip and thigh

144

0.69

0.49

1.2

1.1

—

Benign neoplasm: Skin, unspecified

178

0.73

0.48

1.1

—

Unspecified human immunodeficiency virus [HIV] disease

1.53

0.48

1.0

1.2

—

Assault by unspecified means

102

1.38

0.47

1.1

—

Gestational [pregnancy-induced] hypertension

165

1518

1.09

0.47

1.1

—

19.56

—

Tularaemia, including avohilmo

1.48

0.47

1.2

1.1

—

Melanoma in situ of trunk

1.46

0.47

1.0

1.1

—

Myocardial infarction, with ST-elevation

591

0.86

0.46

1.1

—

9.60

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.43

0.46

1.0

1.1

—

Other protozoal intestinal diseases, including avohilmo

1.39

0.46

1.0

1.1

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.61

0.46

1.0

1.1

—

Contusion of toe(s) without damage to nail

129

1.32

0.46

1.1

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

0.60

0.46

1.0

1.1

—

Venous complications and haemorrhoids in pregnancy

0.59

0.45

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

412

1.17

0.45

1.1

—

4.59

—

Retained placenta and membranes, without haemorrhage

590

1.14

0.45

1.1

—

5.04

—

Mental and behavioural disorders due to cannabinoids

156

1.29

0.45

1.1

—

Abscess of external ear

1.41

0.45

1.0

1.1

—

Congenital deformities of feet, including avohilmo

183

1.26

0.45

1.0

1.1

—

Keratoconus

112

1.34

0.44

1.1

—

Other endocrine disorders

236

1.22

0.44

1.1

—

Burn and corrosion of trunk

121

1.33

0.44

1.1

—

Other condition

714

1.12

0.44

1.1

—

4.24

—

Systemic sclerosis, icd10

1.37

0.44

1.1

—

Femoral hernia, unilateral

1.37

0.44

1.0

1.1

—

Inguinal of femoral hernia, unilateral

1.37

0.44

1.0

1.1

—

Inguinal hernia, unilateral

1.37

0.44

1.0

1.1

—

Psoriatic arthropathies, ICD10

498

1.15

0.43

1.0

1.1

—

4.24

—

Benign neoplasm: Skin of upper limb, including shoulder

1.42

0.43

1.0

1.1

—

Amoebiasis, including avohilmo

1.62

0.43

1.6

1.1

—

Leukaemia of unspecified cell type

1.62

0.43

1.0

1.1

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.41

0.43

1.0

1.1

—

Aortic aneurysm

875

0.90

0.43

1.1

—

33.13

—

Other congenital malformations of the digestive system

192

1.24

0.42

1.1

—

Benign neoplasm: Larynx

113

1.33

0.42

1.1

—

Synovial cyst of popliteal space [Baker]

239

1.22

0.42

1.1

—

5.60

—

Seronegative juvenile rheumatoid arthritis

0.64

0.42

1.2

1.1

—

Defect, injury or illness of neck

1.57

0.42

1.0

1.1

—

Congenital obstruction of the pelviureteric junction

1.57

0.42

1.2

1.1

—

Malignant neoplasm of tongue, including Hilmo

0.64

0.42

1.0

1.1

—

Toxic effect of other and unspecified substances

1.41

0.42

1.3

1.1

—

Open wound of thorax

1.41

0.42

1.4

1.1

—

Cystic kidney disease, including avohilmo

139

0.72

0.42

1.1

—

UC patients in KELA-register (code 208), prior to 1994

184

0.76

0.42

1.1

—

Drug-induced thyroiditis

0.00

0.41

0.0

1.1

—

Sequelae of other accidents

1.38

0.41

1.0

1.1

—

Cleft lip

0.00

0.41

0.0

1.1

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.41

0.0

1.1

—

Other disorders affecting eyelid function

1.52

0.41

1.0

1.1

—

Interstitial cystitis (chronic), drug-induced

0.00

0.41

0.0

1.1

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.41

0.0

1.1

—

Benign neoplasm: Mediastinum

0.00

0.41

0.0

1.1

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.41

0.0

1.0

—

Malignant neoplasm of base of tongue

0.00

0.41

0.0

1.1

—

Other and unspecified water transport accidents

0.00

0.41

0.0

1.3

—

Atrioventricular septal defect

0.00

0.41

0.0

1.0

—

Sequelae of tuberculosis, including avohilmo

1.52

0.41

1.0

—

Complications specific to multiple gestation

0.00

0.41

0.0

1.0

—

Malignant neoplasm of gallbladder

0.00

0.41

0.0

1.1

—

Primary ovarian failure

105

1.34

0.41

1.1

—

Mumps

105

1.34

0.41

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

351

1.17

0.41

1.1

—

5.54

—

Juvenile cataract

0.00

0.41

0.0

1.2

—

Congenital aortic valve stenosis

0.00

0.41

0.0

1.1

—

Paget disease

0.00

0.41

0.0

1.0

—

Malignant neoplasm of gum

0.00

0.41

0.0

1.1

—

Familial erythrocytosis

0.00

0.41

0.0

1.1

—

Other rupture of muscle

0.00

0.41

0.0

1.1

—

Melanoma in situ of lower limb, including hip

1.48

0.40

1.0

1.1

—

Mesial bite

1.48

0.40

1.0

1.1

—

Acute epiglottitis

1.34

0.40

1.0

1.1

—

Open wound of abdomen, lower back and pelvis

141

1.28

0.40

1.1

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

0.40

0.0

1.1

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

0.40

0.0

1.1

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.40

0.0

1.1

—

Valvular operations

550

0.87

0.40

1.1

—

17.64

—

Prolapse and hernia of ovary and fallopian tube

1.42

0.40

1.1

1.0

—

Bronchiectasis

278

1.19

0.40

1.2

1.1

—

4.99

—

Other specified/unspecified nutritional deficiencies

1.44

0.39

1.0

1.1

—

Primary amenorrhea

1.44

0.39

1.0

1.1

—

Impacted maxillary canine

1.43

0.39

1.2

1.1

—

Pulmonary eosinophilia, not elsewhere classified

1.43

0.39

1.2

1.1

—

Melanoma in situ of other and unspecified parts of face

1.43

0.39

1.0

1.1

—

Contact with lifting and transmission devices, not elsewhere classified

1.41

0.39

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

1.43

0.39

1.2

1.0

—

Blood alcohol or alcohol intoxication level

106

0.66

0.39

1.0

1.1

—

Later onset COPD, excluding more controls

455

1.12

0.38

1.1

—

12.80

—

Other injuries of spine and trunk, level unspecified

1.39

0.38

1.0

1.1

—

Androgenic alopecia

1.39

0.38

1.0

1.1

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.39

0.38

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.39

0.38

1.0

1.1

—

Atypical mycobacterium lung infection

1.39

0.38

1.4

1.1

—

Iliotibial band syndrome

1.39

0.38

1.0

1.1

—

Respiratory distress of newborn

1.35

0.38

1.1

1.0

—

Malignant neoplasm of testis, including Hilmo

1.35

0.38

1.1

—

Autism spe, excluding more controls

1.35

0.37

1.0

1.1

—

Other disorders of prostate

1.33

0.37

1.0

1.1

—

Mild mental retardation

114

0.70

0.37

1.0

1.1

—

Palindromic rheumatism

1.36

0.37

1.0

1.1

—

Gout due to impairment of renal function

1.36

0.37

1.0

1.1

—

Left hemicolectomy

1.39

0.37

1.2

1.1

—

Wet age-related macular degeneration

485

0.87

0.36

1.0

1.1

—

4.24

—

Foreign body in genitourinary tract

1.47

0.36

1.2

1.1

—

Congenital malformations of heart and great arteries

657

1.11

0.36

1.1

—

4.32

—

Infections of breast associated with childbirth

189

1.22

0.36

1.1

1.0

—

Congenital malformations of eye, ear, face and neck

328

1.16

0.36

1.0

1.1

—

Other disorders of cornea

422

1.14

0.36

1.0

1.1

—

4.34

—

Whooping cough, including avohilmo

0.63

0.35

1.0

1.1

—

Small cell lung cancer, helper endpoint

0.63

0.35

1.0

1.1

—

Problems related to social environment

1.32

0.35

1.2

1.1

—

Mandibular retrognathia AND surgery (BSSO)

123

0.73

0.35

1.0

1.1

—

Cystic kidney disease

126

0.71

0.35

1.1

—

Carcinoma in situ, bladder

126

0.71

0.35

1.0

1.1

—

Disorders of puberty, all

1.38

0.34

1.2

1.1

—

Benign neoplasm: Scapula and long bones of upper limb

1.37

0.34

1.2

1.1

—

Pure hyperglyceridaemia

1.32

0.34

1.2

1.1

—

Nonischemic cardiomyopathy

393

0.86

0.34

1.1

—

3.05

—

Disorders of continuity of bone

492

1.12

0.32

1.1

—

5.54

—

Schizoid personality disorder

1.36

0.32

1.0

1.1

—

AV-block

591

1.10

0.32

1.1

—

29.35

—

Parapsoriasis

1.33

0.32

1.0

1.1

—

Mixed specific developmental disorders

1.30

0.32

1.1

—

Calcific aortic valvular stenosis, operated

981

0.92

0.32

1.1

—

9.03

—

Calcific aortic valvular stenosis

981

0.92

0.32

1.1

—

9.03

—

Generalized epilepsy, strict definition

1.31

0.32

1.0

1.1

—

Congenital deformities of feet

119

1.26

0.32

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

980

0.92

0.31

1.1

—

9.03

—

Operations 2 for CAVS

980

0.92

0.31

1.1

—

9.03

—

Lichen planus

541

1.11

0.31

1.1

—

5.75

—

Localized scleroderma [morphea]

1.35

0.31

1.0

1.1

—

Other congenital malformations of intestine, including avohilmo

1.33

0.31

1.0

1.1

—

Other and unspecified mental retardation

1.34

0.31

1.1

—

Cardiomyopathy, other and unspecified

305

1.15

0.30

1.0

1.1

—

0.73

—

Benign neoplasm: Stomach

371

1.13

0.30

1.1

—

4.70

—

Premature rupture of membranes

133

1011

0.94

0.30

1.1

—

6.04

—

Other psoriatic arthropathies

485

1.11

0.30

1.0

1.1

—

4.24

—

Arteriovenous malformation of cerebral vessels

1.30

0.30

1.0

1.1

—

Entropion and trichiasis of eyelid

249

1.17

0.30

1.3

1.1

—

1.63

—

Malignant neoplasm of colon

568

0.90

0.30

1.1

—

1.06

—

Pervasive developmental disorders excl. Autism + Asperger

1.28

0.30

1.1

—

Umbilical hernia

148

1392

1.06

0.30

1.1

—

11.91

—

Personal history of allergy to drugs, medicaments and biological substances

1.28

0.30

1.0

1.1

—

Campylobacter enteritis

111

1.26

0.30

1.1

—

Granuloma annulare

1.28

0.30

1.0

1.1

—

Bullous pemphigoid

1.28

0.30

1.0

1.1

—

908

0.93

0.30

1.1

—

9.40

—

Early syphilis

1.25

0.29

1.3

1.1

—

Major anomalies of jaw size

130

0.77

0.29

1.0

1.1

—

Other obstructive and reflux uropathy

185

1.19

0.29

1.0

1.1

—

Family history of other specific disorders

1.23

0.29

1.1

—

Herpesviral keratitis and keratoconjunctivitis

167

1.20

0.28

1.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

983

0.93

0.28

1.1

—

9.03

—

Ulcerative enterocolitis

140

0.78

0.28

1.0

1.1

—

Poisoning by medicine, drug-induced

1.27

0.28

1.0

1.1

—

Early syphilis, including avohilmo

1.27

0.28

1.3

1.1

—

Crushing injury of wrist and hand

1.27

0.28

1.1

—

Ankyloglossia

1.32

0.27

1.3

1.1

—

HSIL lesion of the vagina

1.25

0.27

1.1

—

CR(E)ST syndrome

1.25

0.27

1.0

1.1

—

Benign neoplasm of ovary

710

1.09

0.27

1.1

—

5.02

—

Disorders of puberty

1.23

0.27

1.3

1.1

—

Duodenal ulcer

375

1.12

0.27

1.0

1.1

—

3.05

—

Other infestations, including avohilmo

1.21

0.27

1.0

—

Car occupant injured in noncollision transport accident

159

1.20

0.26

1.1

—

Mumps, including avohilmo

113

1.24

0.26

1.1

—

Struck by thrown, projected or falling objec

262

1.15

0.26

1.1

—

Benign neoplasm: Short bones of upper limb

1.20

0.26

1.0

1.1

—

Pedal cyclist injured in transport accident

130

1225

1.06

0.26

1.0

1.1

—

12.11

—

Viral agents as the cause of diseases classified to other chapters

1.28

0.26

1.0

1.1

—

Cleft lip, lip and palate or palate

0.69

0.26

1.0

1.1

—

Injury of urinary and pelvic organs

1.30

0.26

1.0

1.1

—

Malignant neoplasm of tonsil and base of tongue

0.67

0.26

1.0

1.1

—

Small cell lung cancer, including Hilmo

0.67

0.26

1.0

1.1

—

Small cell lung cancer

0.67

0.26

1.0

1.1

—

Other vitreous opacities

169

1.19

0.26

1.1

—

Other arterial embolism and thrombosis

0.67

0.26

1.0

1.1

—

Other congenital malformations, including avohilmo

712

1.08

0.26

1.1

—

3.54

—

Malignant neoplasm of skin

247

1602

1.04

0.25

1.1

—

30.04

—

Injury of muscle and tendon at ankle and foot level

105

1.24

0.25

1.2

1.1

—

COPD related to multimorbidity

166

1334

1.05

0.24

1.1

—

26.37

—

LSIL lesion of the cervix uteri, vagina or vulva

821

1.07

0.24

1.1

—

26.36

—

Other assisted single delivery

1.27

0.24

1.0

1.1

—

Bursitis of shoulder

1.27

0.24

1.1

—

Amputation of foot

0.73

0.24

1.0

1.1

—

Premenstrual syndrome

0.70

0.24

1.3

1.1

—

Contact with sharp object, undetermined intent

115

1.22

0.23

1.0

1.1

—

Unspecified lump in breast

726

1.08

0.23

1.1

—

5.02

—

Benign neoplasm: Skin of eyelid, including canthus

639

1.08

0.23

1.1

—

4.59

—

Malignant neoplasm of vulva

1.32

0.23

1.2

1.1

—

Acquired stenosis of external ear canal

1.32

0.23

1.0

1.1

—

Other blood glucose lowering drugs, excl. Insulins

591

1.08

0.23

1.2

1.1

—

9.93

—

Sequelae of injuries of upper limb

466

1.10

0.23

1.1

—

4.24

—

Cyst of kidney

275

1.13

0.23

1.1

—

2.82

—

Benign neoplasm: Other parts of oropharynx

1.29

0.23

1.0

1.1

—

Mantle cell lymphoma, including Hilmo

1.28

0.23

1.0

1.2

—

Inflammation of lacrimal passages (chronic)

1.28

0.23

1.2

1.0

—

651

1.08

0.23

1.1

—

3.84

—

Congenital malformations of breast, including avohilmo

0.75

0.22

1.0

1.1

—

Mixed disorders of conduct and emotions

125

1.20

0.22

1.1

1.0

—

Carbimazole or st.post thyroidectomy, condition for graves disease

113

1068

1.06

0.22

1.1

—

5.03

—

Torsion of testis

1.27

0.22

1.0

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

104

950

1.06

0.22

1.1

—

34.66

—

Other diseases of appendix

1.22

0.22

1.0

1.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

144

1.18

0.22

1.1

—

Poor fetal growth

762

0.93

0.22

1.0

1.1

—

24.53

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.21

0.0

1.0

—

Diphtheria

0.00

0.21

0.0

1.1

—

Ependymoma

0.00

0.21

0.0

1.3

—

Microtia (small ears)

0.00

0.21

0.0

1.2

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.21

0.0

1.0

—

Aortic arch syndrome [Takayasu]

0.00

0.21

0.0

1.0

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.21

0.0

1.1

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.21

0.0

1.2

—

Bilateral cryptorchidism (undescended testicles)

0.00

0.21

0.0

1.0

—

Fractures involving multiple body regions

0.00

0.21

0.0

1.3

—

Congenital malformations of anterior segment of eye

1.19

0.21

1.0

1.1

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.21

0.0

1.0

—

Noninfective disorders of pinna

0.00

0.21

0.0

1.0

—

Cystic fibrosis

0.00

0.21

0.0

1.0

—

Urticaria due to cold and heat

1.19

0.21

1.2

1.1

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.21

0.0

1.1

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.21

0.0

1.1

—

Airway disease due to specific organic dust

0.00

0.21

0.0

1.0

—

Eccrine sweat disorders

0.00

0.21

0.0

1.2

—

Sickle-cell disorders

0.00

0.21

0.0

1.2

—

Congenital lactase deficiency

0.00

0.21

0.0

1.3

—

Intestinal helminthiases, other/unspecified, including avohilmo

0.00

0.21

0.0

1.1

—

Phantom limb syndrome

0.00

0.21

0.0

1.2

—

Acquired atrophy of ovary and fallopian tube

0.00

0.21

0.0

1.0

—

Other and unspecified cicatricial alopecia

0.00

0.21

0.0

1.0

—

Evidence of alcohol involvement determined by level of intoxication

1.19

0.21

1.0

1.1

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.21

0.0

1.2

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.21

0.0

1.2

—

Secondary systemic amyloidosis

0.00

0.21

0.0

1.1

—

Chondrosarcoma

0.00

0.21

0.0

1.2

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.21

0.0

1.2

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.21

0.0

1.2

—

Gastrojejunal ulcer

1.19

0.21

1.0

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.21

0.0

1.0

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.21

0.0

1.1

—

Defect, injury or illness of lumbar spine

0.00

0.21

0.0

1.3

—

Erectile dysfunction, exclusion

0.00

0.21

0.0

1.1

—

Nezelof syndrome

0.00

0.21

0.0

1.2

—

ILD medications: nintedanib

0.00

0.21

0.0

1.1

—

ILD medications: acetylcysteine

0.00

0.21

0.0

1.1

—

Hypoplasia of dental enamel

1.19

0.21

1.0

1.1

—

Diphtheria, including avohilmo

0.00

0.21

0.0

1.1

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.21

0.0

1.2

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.21

0.0

1.3

—

Enteropathogenic Escherichia coli infection

0.00

0.21

0.0

1.2

—

Carcinoma in situ of breast

0.00

0.21

0.0

1.0

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.1

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.1

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.1

—

Malignant neoplasm of small intestine, including Hilmo

102

0.78

0.21

1.0

1.1

—

Psoriasis (vulgaris), strict definition

154

1.17

0.21

1.1

—

Benign neoplasm: Oesophagus

1.16

0.21

1.0

1.1

—

Benign neoplasm: Skin of lip

1.16

0.21

1.0

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.0

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.1

—

Exposure to controlled fire, not in building or structure

0.00

0.21

0.0

1.0

—

Other secondary gout

0.00

0.21

0.0

1.0

—

Rheumatic fever without mention of heart involvement

0.00

0.21

0.0

1.2

—

Changes in corneal membranes

0.00

0.21

0.0

1.1

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.21

0.0

1.3

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.21

0.0

1.2

—

Postpartum haemorrhage due to anatomy

646

0.93

0.20

1.1

—

24.53

—

Conductive hearing loss, unspecified

364

1.10

0.20

1.1

—

5.62

—

Lordosis

0.00

0.20

0.0

1.2

—

Open bite that required surgery (Lefort1 or BSSO)

1.25

0.20

1.0

1.1

—

Prominent ears

1.25

0.20

1.0

1.1

—

Chronic thyroiditis

0.00

0.20

0.0

1.2

—

Striae atrophicae

1.25

0.20

1.0

1.1

—

Other disorders of amino-acid metabolism

0.00

0.20

0.0

1.1

—

Pedestrian injured in other and unspecified transport accidents

1.25

0.20

1.0

1.1

—

Alcoholic cardiomyopathy

0.00

0.20

0.0

1.1

—

Golimumab

183

1.15

0.20

1.0

1.1

—

Early complications of trauma

202

1.14

0.20

1.2

1.1

—

!Aliquae complicationes praecoces traumatis

202

1.14

0.20

1.2

1.1

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.20

0.20

1.5

1.1

—

Ulcerative colitis, NAS

714

1.07

0.19

1.1

—

16.03

—

Puerperal sepsis

569

1.07

0.19

1.0

1.1

—

5.04

—

Hypersensitivity pneumonitis due to organic dust

1.13

0.18

1.3

1.1

—

Rheumatic valve diseases

1.21

0.18

1.0

1.1

—

Anorexia

1.19

0.18

1.0

1.1

—

Vascular disorders of the intestines

223

1.12

0.18

1.1

—

4.14

—

Lichen planus, including avohilmo

853

1.06

0.18

1.1

—

4.21

—

Dissocial personality disorder

1.17

0.18

1.0

1.1

—

Carcinoma in situ of cervix uteri, endocervix

1.15

0.17

1.0

1.1

—

Diseases caused by chlamydiae, including avohilmo

1.15

0.17

1.0

1.1

—

Thyroiditis, unspecified

1.13

0.17

1.3

1.1

—

Toxic liver disease

1.13

0.17

1.0

1.1

—

Cardiomyopathy

732

0.94

0.17

1.0

1.1

—

30.38

—

Pemphigoid

1.22

0.17

1.0

1.1

—

Unspecified maternal hypertension

1.11

0.17

1.0

1.1

—

Hydatidiform mole

1.11

0.17

1.0

1.1

—

Male infertility

224

1.12

0.17

1.1

—

Pyogenic granuloma

0.73

0.17

1.0

1.1

—

Paranoid personality disorder

0.73

0.17

1.0

1.1

—

Inguinal hernia

316

2155

0.97

0.17

1.1

22.40

10.18

au/ml

—

Gingival hyperplasia

167

1.14

0.17

1.0

1.1

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.71

0.16

1.0

1.1

—

Bilateral sagittal split ramus osteotomy operation

173

0.87

0.16

1.1

—

Other congenital malformations of tongue, mouth and pharynx

1.17

0.16

1.4

1.1

—

Family history of other conditions

1.14

0.16

1.1

1.0

—

Malignant neoplasm of head and neck, including Hilmo

360

0.92

0.16

1.1

—

0.28

—

Haemangioma, any site

389

1.08

0.16

1.0

1.1

—

4.24

—

conjunctival degenerations and deposits

1.10

0.15

1.0

1.1

—

Gonococcal infection, including avohilmo

172

0.87

0.15

1.1

—

Malignant neoplasm of cervix uteri

0.78

0.15

1.2

1.1

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.78

0.15

1.0

1.1

—

Contact with heat and hot substances

264

1.10

0.15

1.1

—

Burn and corrosion of head and neck

1.21

0.15

1.1

—

Other specified congenital malformation syndromes affecting multiple systems

1.16

0.15

1.0

1.1

—

102

1.18

0.15

1.1

1.0

—

Other specific arthropathies, wide

1.13

0.15

1.0

1.1

—

Malignant neoplasm of other connective and soft tissue

1.11

0.15

1.3

1.1

—

Graves disease, strict definition

527

1.06

0.14

1.1

—

4.75

—

Congenital malformations of breast

0.80

0.14

1.0

1.1

—

Non-ischemic cardiomyopathy

133

1094

0.96

0.14

1.1

—

28.08

—

LeFortI or BSSO operation

212

0.90

0.14

1.1

—

Congenital malformations of great arteries

0.83

0.14

1.0

1.1

—

Enteropathic arthropathies

0.81

0.13

1.0

1.1

—

Acute alcohol intoxication ICD-9

128

0.86

0.13

1.0

1.1

—

Ventral hernia

104

1082

0.96

0.13

1.1

—

12.54

—

Wide developmental disorders

179

1.11

0.13

1.1

—

Personal history of other diseases and conditions

650

0.95

0.13

1.1

—

4.32

—

Postprocedural musculoskeletal disorders, not elsewhere classified

286

1.08

0.13

1.3

1.1

—

4.70

—

Allergic purpura

113

1.15

0.13

1.2

1.1

—

Medical treatment for female infertility

131

1342

0.97

0.13

1.1

—

25.47

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

612

0.95

0.13

1.0

1.1

—

4.85

—

Injury of intra-abdominal organs

108

0.83

0.13

1.1

—

Benign neoplasm: Tongue

108

0.83

0.13

1.2

1.1

—

Basal cell carcinoma, including Hilmo

214

1411

1.03

0.13

1.1

—

32.63

—

Pedal cyclist injured in other and unspecified transport accidents

560

1.05

0.12

1.0

1.1

—

3.54

—

Pedestrian injured in collision with pedal cycle

123

1.14

0.12

1.1

—

Ill-defined and unknown causes of mortality

326

1.07

0.12

1.0

1.1

—

4.22

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

201

1398

0.98

0.11

1.1

—

32.63

—

Haemangioma and lymphangioma, any site

415

1.06

0.11

1.0

1.1

—

4.24

—

Fracture of femur

102

888

1.04

0.11

1.1

—

3.94

—

Carcinoma in situ of other and unspecified genital organs

1.16

0.11

1.1

—

Epiphora

1.16

0.11

1.0

1.1

—

Insulin, fast-acting (human)

750

1.04

0.10

1.1

—

3.65

—

Thoracic aortic aneurysm

593

1.05

0.10

1.1

—

21.77

—

Noise effects on inner ear

173

1.10

0.10

1.2

1.1

—

Malignant neoplasm of colon, including Hilmo

679

1.04

0.10

1.1

—

1.06

—

Exclusion endpoint for clefts

1.15

0.10

1.0

1.1

—

Ankylosing spondylitis, strict definition

222

1.08

0.10

1.0

1.1

—

Myotonic disorders

1.14

0.10

1.0

1.1

—

Gastrointestinal stromal tumor and sarcoma

1.14

0.10

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.14

0.10

1.2

1.1

—

Acute poliomyelitis

1.14

0.10

1.2

1.1

—

Acute poliomyelitis, including avohilmo

1.14

0.10

1.2

1.1

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.11

0.10

1.2

1.1

—

Idiopathic urticaria

114

0.88

0.09

1.1

—

Use of biperiden

242

1.08

0.09

1.1

—

Other congenital malformations of female genitalia

1.06

0.09

1.0

1.1

—

Other immunodeficiencies

1.06

0.09

1.2

1.1

—

Postpartum haemorrhage due to retained placenta

737

0.96

0.09

1.0

1.1

—

24.53

—

Carcinoma in situ of rectum

1.04

0.09

1.0

—

Benign neoplasm: Bronchus and lung

1.04

0.09

1.2

1.1

—

Suppurative otitis media, unspecified

116

1.12

0.09

1.0

1.1

—

Benign neoplasm: Skin of scalp and neck

1.14

0.09

1.3

1.1

—

Osteonecrosis due to drugs

1.09

0.09

1.0

1.1

—

Benign neoplasm: Other and unspecified parts of small intestine

1.09

0.09

1.2

1.1

—

Autism spe

134

0.89

0.08

1.0

1.1

—

Universal erythroderma, KELA reimbursement

1.07

0.08

1.0

1.1

—

Guttate psoriasis

1.05

0.08

1.0

1.1

—

Abscess of lung

1.05

0.08

1.0

1.1

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.05

0.08

1.0

1.1

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.04

0.08

1.0

1.1

—

Vitiligo

1.03

0.08

1.2

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.03

0.08

1.0

1.1

—

Portal vein thrombosis

1.03

0.08

1.0

1.1

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.03

0.08

1.0

1.1

—

Carcinoma in situ of colon

113

0.88

0.08

1.2

1.1

—

Conotruncal defects

0.82

0.08

1.0

1.1

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.83

0.08

1.2

1.1

—

Malignant neoplasm of oropharynx

0.82

0.08

1.0

1.1

—

Malignant neoplasm of tonsil, including Hilmo

0.83

0.08

1.0

1.1

—

Respiratory conditions due to other external agents

0.83

0.08

1.0

1.1

—

Gonococcal infection

154

0.91

0.08

1.0

1.1

—

Myeloid leukaemia

1.14

0.08

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

189

1363

1.02

0.08

1.1

—

29.72

—

Benign mammary dysplasia

578

1.04

0.08

1.1

—

5.02

—

Other diseases caused by chlamydiae, including avohilmo

1.05

0.08

1.0

1.1

—

Labour and delivery complicated by fetal stress [distress]

162

1075

0.98

0.08

1.1

—

14.00

—

Other congenital malformations of ear

1.03

0.08

1.0

1.1

—

Malignant neoplasm of oropharynx, including Hilmo

0.86

0.07

1.0

1.1

—

Infective bursitis

1.12

0.07

1.1

—

Need for immunization against other single viral diseases

0.80

0.07

1.2

1.1

—

Benign neoplasm: Lip

0.80

0.07

1.0

1.1

—

Benign neoplasm: Vulva

1.07

0.07

1.0

1.1

—

Pedal cyclist injured in collision with motor vehicle

147

1.09

0.07

1.0

1.1

—

Toxic effect of alcohol

0.85

0.07

1.1

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.82

0.07

1.0

1.1

—

Stenosis and insufficiency of lacrimal passages

363

1.05

0.07

1.2

1.1

—

2.18

—

Other disorders of breast and lactation associated with childbirth

1.06

0.07

1.1

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

1.04

0.07

1.3

1.1

—

Nephrotic syndrome

122

0.90

0.07

1.2

1.1

—

Chronic mastoiditis

1.03

0.07

1.0

1.1

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

417

0.96

0.06

1.1

—

5.04

—

Complications associated with artificial fertilization

1.11

0.06

1.2

1.1

—

Polycystic kidney disease

100

0.90

0.06

1.1

—

Malignant neoplasm of cervix uteri, including Hilmo

103

0.87

0.06

1.1

—

Pterygium

105

0.86

0.06

1.2

1.1

—

Hernia of abdominal wall

236

2390

0.99

0.06

1.1

—

22.15

—

Contact with other hot fluids

141

0.92

0.05

1.1

—

Basal cell carcinoma

201

1352

1.01

0.05

1.1

—

32.63

—

Schizotypal disorder

110

1.09

0.05

1.0

1.1

—

Exposure to other specified electric current

110

1.09

0.05

1.1

—

Other congenital malformations of face and neck

130

1.08

0.04

1.0

1.1

—

Pedestrian injured in collision with car, pick-up truck or van

101

1.09

0.04

1.0

1.1

—

Isolated proteinuria

109

0.92

0.04

1.1

—

Contact with and exposure to communicable diseases

196

1971

0.99

0.04

1.1

—

21.83

—

Abnormal findings on examination of urine, without diagnosis

180

1.06

0.04

1.1

—

Autism

129

0.93

0.03

1.0

1.1

—

Benign neoplasm: Liver

108

0.93

0.03

1.1

—

Graves ophthalmopathy

108

0.93

0.03

1.2

1.1

—

Hyperaldosteronism

112

1.07

0.03

1.1

—

Post-traumatic wound infection, not elsewhere classified

112

1.07

0.03

1.0

1.1

—

Benign neoplasm: Liver/bile ducts

118

0.93

0.02

1.1

—

Postpartum hemorraghe, parous women as controls

161

1334

1.01

0.02

1.1

—

19.79

—

Acute appendicitis, with complications

878

1.01

0.02

1.1

—

15.49

—

Short stature, not elsewhere classified

104

1.07

0.02

1.2

1.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

620

1.02

0.02

1.1

—

11.42

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

389

0.98

0.02

1.1

—

5.04

—

Ovarian hyperstimulation (induction)

1.08

0.02

1.0

1.1

—

Primary gonarthrosis, bilateral

239

1989

1.01

0.02

1.1

—

27.90

—

Postpartum haemorrhage

161

1337

0.99

0.01

1.1

—

23.02

—

Benign neoplasm of mouth and pharynx

462

1.02

0.01

1.1

—

4.29

—

LSIL lesion of the cervix uteri

682

1.01

0.01

1.1

—

25.37

—

Macular pucker

597

0.99

0.01

1.1

—

10.30

—

Benign neoplasm: Pancreas

106

0.94

0.01

1.1

—

Granulomatous disorders of skin and subcutaneous tissue

106

0.94

0.01

1.0

1.1

—

Toxic effect of ethanol

186

0.97

0.00

1.0

1.1

—

Atopic conjunctivitis

206

0.97

0.00

1.1

—

Thyrotoxicosis with toxic multinodular goitre

224

1.03

0.00

1.0

1.1

—

5.37

—

Spermatocele

254

1.02

0.00

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

218

1475

1.00

0.00

1.1

—

32.63

—

Postpartum hemorraghe, all women as controls

161

1564

1.00

0.00

1.1

—

23.92

—

Contact with nonpowered hand tool

199

1.01

0.00

1.1

—

Polycystic ovarian syndrome, broad definition

715

1.01

0.00

1.1

—

26.03

—

IgA nephropathy (IgA glomerulonephritis)

1.02

0.00

1.2

1.1

—

Dissection of aorta

102

0.98

0.00

1.0

—

Alcohol-induced acute pancreatitis

168

1.01

0.00

1.1

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

232

0.99

0.00

1.1

—

5.04

—

Pacemaker

139

1292

1.00

0.00

1.0

1.1

—

27.60

—

Other disorders of bone density and structure

109

1.01

0.00

1.0

1.1

—

Juvenile osteochondrosis

149

1.01

0.00

1.0

1.1

—

Mental retardation

183

0.97

0.00

1.1

—

Left bundle-branch block

295

1.02

0.00

1.2

1.1

—

2.05

—

Chromosomal abnormalities, not elsewhere classified

1.05

0.00

1.1

—

Traumatic amputation of wrist and hand

172

0.99

0.00

1.1

—

Mental retardation, wide definition

193

0.98

0.00

1.1

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.03

0.00

1.2

1.1

—

Disorders of eyelid in diseases classified elsewhere

133

0.98

0.00

1.1

—

Other specified disorders of external ear

147

1.02

0.00

1.0

1.1

—

Pyothorax

173

0.98

0.00

1.1

—

Artificial joint re-operation

247

1.01

0.00

1.1

—

4.70

—

Graves ophthalmopathy, strict

1.05

0.00

1.2

1.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

151

0.99

0.00

1.0

1.1

—

Melanocytic naevi of scalp and neck

0.91

0.00

1.0

1.1

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

Laparoscopic left hemicolectomy

1.00

0.00

1.2

1.1

—

Other fibroblastic disorders

0.00

0.0

1.0

—

Acne varioliformis

0.00

0.0

1.4

—

Alport

0.00

0.0

1.3

—

Choroidal detachment

0.00

0.0

1.0

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

Cardiomyopathy due to drugs and other external agents

0.00

0.0

1.0

—

Cyst of spleen

0.00

0.0

1.2

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.96

0.00

1.1

—

Pectus carinatum

0.00

0.0

1.3

—

Drug-induced gout

0.00

0.0

1.0

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

0.0

1.0

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.0

1.0

—

Hypertensive Renal Disease

0.96

0.00

1.0

1.1

—

4.22

—

Malignant neoplasm of vulva, including Hilmo

1.00

0.00

1.2

1.1

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.0

1.0

—

Single ventricle heart

0.00

0.0

1.0

—

Hereditary lymphedema, including avohilmo

0.00

0.0

1.3

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.0

—

Secondary sideroblastic anaemia

0.00

0.0

1.0

—

Hypotony of eye

0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites

0.88

0.00

1.2

1.1

—

Malignant neoplasm of eye and adnexa, including Hilmo

0.98

-0.00

1.0

1.1

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.0

—

Injury of heart

0.00

-0.00

0.0

1.2

—

Perichondritis of external ear

0.98

-0.00

1.6

1.1

—

Other changes in lacrimal passages

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of globe

0.00

-0.00

0.0

1.0

—

Disorders of vagus nerve

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.0

—

Induced delusional disorder

0.00

-0.00

0.0

1.0

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.3

—

Injury of muscle and tendon at forearm level

0.98

-0.00

1.0

1.1

—

Deep bite that required surgery

0.98

-0.00

1.2

1.1

—

Digestive system disorders of fetus and newborn

0.00

-0.00

0.0

1.0

—

Malignant otitis externa

0.00

-0.00

0.0

1.0

—

Asymmetry of jaw

0.88

-0.00

1.0

1.1

—

Assault by sharp object

1.00

-0.00

1.1

—

Traumatic amputation of shoulder and upper arm

0.00

-0.00

0.0

1.1

—

Migraine with aura, drug-induced

1.02

-0.00

1.0

1.1

—

Disorders of tyrosine metabolism

0.00

-0.00

0.0

1.0

—

Maxillary retrognathism

0.95

-0.00

1.1

—

Disorders of urea cycle metabolism

0.00

-0.00

0.0

1.0

—

Ascorbic acid deficiency

0.00

-0.00

0.0

1.0

—

Asphyxiation

0.00

-0.00

0.0

1.3

—

Juvenile rheumatoid arthirtis

0.99

-0.00

1.1

—

Lipoprotein deficiency

0.00

-0.00

0.0

1.2

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.0

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

Iodine-deficiency-related goitre

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to alcohol

1.00

-0.00

1.1

—

Polydactyly

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.02

-0.00

1.0

1.1

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.0

—

Hyperchylomicronaemia

0.00

-0.00

0.0

1.1

—

Assault by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

Other porphyria

0.00

-0.00

0.0

1.0

—

Other nonscarring hair loss

0.98

-0.00

1.0

1.1

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.2

—

Drug-induced hypopituitarism

0.00

-0.00

0.0

1.2

—

Folliculitis decalvans

0.00

-0.00

0.0

1.0

—

Follicular keratosis (Darier-White), including avohilmo

0.00

-0.00

0.0

1.3

—

Hereditary lymphedema

0.00

-0.00

0.0

1.3

—

Spina bifida

0.00

-0.00

0.0

1.3

—

Turner's syndrome

0.00

-0.00

0.0

1.3

—

Other and unspecified hereditary haemolytic anaemias

0.00

-0.00

0.0

1.0

—

Other and unspecified haemorrhagic conditions

0.91

-0.00

1.0

1.1

—

Solar urticaria

0.00

-0.00

0.0

1.2

—

Melanoma in situ of scalp and neck

0.00

-0.00

0.0

1.0

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.0

—

Lumbosacral spina bifida and hydrocephalus

0.00

-0.00

0.0

1.3

—

Carcinoma in situ of anus and anal canal

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of penis

0.00

-0.00

0.0

1.1

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.0

—

Fusion of the labia, including avohilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of tonsil

0.88

-0.00

1.0

1.1

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of trachea, including Hilmo

0.00

-0.00

0.0

1.0

—

Congenital heart conduction disorder

0.00

-0.00

0.0

1.1

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.4

—

Benign neoplasm: Floor of mouth

0.00

-0.00

0.0

1.4

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.2

—

Pulmonary artery stenosis

0.00

-0.00

0.0

1.0

—

Noonan syndrome

0.00

-0.00

0.0

1.3

—

Primary Sclerosing Cholangitis, IBD and UDCA required

1.01

-0.00

1.0

1.1

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.0

—

Profound mental retardation

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

0.87

-0.00

1.0

1.1

—

Hereditary angioödema type 1

0.00

-0.00

0.0

1.0

—

Hypergammalglobulinemia, unspecified

0.00

-0.00

0.0

1.0

—

Supernumerary ureter

0.00

-0.00

0.0

1.3

—

Ventricular septal defect, a heart condition

0.91

-0.00

1.0

1.1

—

Aggressive periodontitis

0.94

-0.00

1.0

1.1

—

Malignant neoplasm of small intestine

0.91

-0.00

1.0

1.1

—

Malignant neoplasm of oropharyng

0.00

-0.00

0.0

1.1

—

Ebstein's anomaly

0.00

-0.00

0.0

1.2

—

Osteogenesis imperfecta

0.00

-0.00

0.0

1.3

—

Congenital glaucoma

0.00

-0.00

0.0

1.0

—

Disorders of amino-acid transport

0.00

-0.00

0.0

1.0

—

Other leukaemias of specified cell type

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.0

—

Postinflammatory hyperpigmentation

0.00

-0.00

0.0

1.4

—

Obstetric embolism

0.00

-0.00

0.0

1.0

—

Calcinosis cutis

0.00

-0.00

0.0

1.0

—

Squamous cell neoplasms and carcinoma of rectum

0.00

-0.00

0.0

1.0

—

Fracture of spine, level unspecified

0.00

-0.00

0.0

1.0

—

Unspecified hairloss

0.00

-0.00

0.0

1.0

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.0

—

Pemphigus foliaceus

0.00

-0.00

0.0

1.0

—

Hirsprung

0.00

-0.00

0.0

1.0

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.0

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.0

—

Disorder of bilirubin metabolism, other/unspecified

0.00

-0.00

0.0

1.0

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.1

—

Medullary carcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Other disorders of bone development and growth

0.00

-0.00

0.0

1.4

—

Operations for atrial fibrillation

0.98

-0.00

1.0

1.1

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

0.94

-0.00

1.2

1.1

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.3

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.4

—

Nutritional marasmus

0.00

-0.00

0.0

1.0

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.0

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.3

—

Plasmodium falciparum malaria, including avohilmo

0.00

-0.00

0.0

1.0

—

Dengue, including avohilmo

0.00

-0.00

0.0

1.3

—

Other parasitologically confirmed or unspecified malaria

0.00

-0.00

0.0

1.0

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.3

—

Other hypertrophic osteoarthropathy

0.00

-0.00

0.0

1.0

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.3

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.0

—

Myiasis, including avohilmo

0.00

-0.00

0.0

1.0

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

-0.00

0.0

1.4

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

1.0

—

Cholera

0.00

-0.00

0.0

1.3

—

Convulsions of newborn

0.00

-0.00

0.0

1.0

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.0

—

Transepidermal elimination disorders

0.00

-0.00

0.0

1.0

—

Cystic fibrosis with intestinal manifestations

0.00

-0.00

0.0

1.0

—

Lichen striatus

0.00

-0.00

0.0

1.2

—

Dependent personality disorder

0.95

-0.00

1.0

1.1

—

Hereditary factor VIII deficiency

0.00

-0.00

0.0

1.0

—

Cholera, including avohilmo

0.00

-0.00

0.0

1.4

—

Traumatic secondary and recurrent haemorrhage

0.00

-0.00

0.0

1.0

—

Multiple congenital exostoses, including avohilmo

0.00

-0.00

0.0

1.3

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

-0.00

0.0

1.3

—

Cystic fibrosis with pulmonary manifestations

0.00

-0.00

0.0

1.0

—

Rheumatic fever incl heart disease

0.96

-0.00

1.0

1.1

—

Other recurrent vertebral subluxation

0.00

-0.00

0.0

1.3

—

Other helminthiases

0.00

-0.00

0.0

1.0

—

Multiple congenital exostoses

0.00

-0.00

0.0

1.3

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.0

—

Polyp of middle ear

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS